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COMPREHENSIVE INVITED REVIEW
Disulfides as Redox Switches: From Molecular Mechanisms
to Functional Significance
Merridee A. Wouters,1,2 Samuel W. Fan,1,2 and Naomi L. Haworth1
Abstract
The molecular mechanisms underlying thiol-based redox control are poorly defined. Disulfide bonds between
Cys residues are commonly thought to confer extra rigidity and stability to their resident protein, forming a type
of proteinaceous spot weld. Redox biologists have been redefining the role of disulfides over the last 30–40 years.
Disulfides are now known to form in the cytosol under conditions of oxidative stress. Isomerization of extra-
cellular disulfides is also emerging as an important regulator of protein function. The current paradigm is that
the disulfide proteome consists of two subproteomes: a structural group and a redox-sensitive group. The redox-
sensitive group is less stable and often associated with regions of stress in protein structures. Some characterized
redox-active disulfides are the helical CXXC motif, often associated with thioredoxin-fold proteins; and for-
bidden disulfides, a group of metastable disulfides that disobey elucidated rules of protein stereochemistry. Here
we discuss the role of redox-active disulfides as switches in proteins. Antioxid. Redox Signal. 12, 53–91.
I. Introduction 54
II. Types of Disulfide Switches 54
A. Discovery of the Cross-Strand Disulfide 55
B. Energetic analysis of allowed disulfide contexts 57
C. Between-strand disulfides 58
D. Other canonical forbidden disulfides 59
E. Other forbidden disulfides 61
F. Folds associated with forbidden disulfides 62
G. Latency in bistable switches 62
1. Latently reduced switches 63
2. Latently oxidized switches 63
III. Determinants of the Redox Potential 64
A. Role of primary structure in determining the redox potential 64
B. Role of secondary structure in determining redox potential 66
C. Influence of conformational changes and measurement technique 66
IV. Switching of Redox-Active Disulfides 66
A. Cellular transport as a switching mechanism 67
B. Redox gradients at the organismal level 67
C. Disulfide relays and cascades 67
1. Disulfide relays 67
2. Disulfide cascades 67
3. Ramping and alternate pathways 68
D. Irreversible redox switches 69
E. Occult sites 70
V. Conformational Changes in Redox Transitions 70
A. Redox-associated morphing transitions 70
B. Redox regulation of the quaternary state 71
C. Redox switches, domain swapping, and amyloid formation 71
VI. Systems Biology Approaches 74
Reviewing Editors: Miriam Cortese-Krott, Jay Hanas, Klaus Kroencke, Jason Larabee, Hui Lu, F. Wayne Outten,
and Peep Palumaa
1Structural & Computational Biology Division, Victor Chang Cardiac Research Institute, Sydney, Australia.
2School of Medical Sciences, University of New South Wales, Sydney, Australia.
ANTIOXIDANTS & REDOX SIGNALING
Volume 12, Number 1, 2010
ª Mary Ann Liebert, Inc.
DOI: 10.1089=ars.2009.2510
53
A. Phosphorylation, calcium, and peroxide 74
B. The role of Zn2þ in thiol-based redox activity 74
1. Zn2þ sites in proteins 74
2. Proteins harboring Zn2þ sites and their conformational changes 75
3. Zn2þ as a second messenger and its physiologic significance 77
VII. Global Approaches to Identifying Redox-Active Cys 78
A. Proteomic approaches to identification of redox-active Cys 78
B. Bioinformatic approaches to prediction of redox-active Cys 79
VIII. Evolution of Thiol-Based Redox Regulation 80
A. Evolution of protein cysteine content 80
B. Origins of thiol-based redox signaling 81
C. Redox-regulation of cysteine-based enzymes 81
IX. Conclusions 82
I. Introduction
Cysteine (Cys) has a remarkable ability to react andbe modified by its environment. Next to histidine, the
pKa of Cys is closest to neutral, rendering both of these amino
acids ionizable upon variations in physiologic pH. As a result,
these residues can act as pH sensors in their resident proteins.
Histidine’s role as a pH sensitive switch is well known. His-
tidines trigger a major conformational change in influenza
hemaglutinin when exposed to changes in pH during traf-
ficking in endosomes (34). Many other cases of histidine-
mediated pH-dependent conformational changes have been
documented.
In contrast, the role of Cys in pH-dependent conforma-
tional changes has been little studied. Cys is also susceptible
to a variety of modifications by reactive oxygen and nitrogen
oxide species (ROS=RNS). Cys can be nitrosated, glutathio-
nylated, and can form covalent bonds with other Cys. RNS
such as nitric oxide (·NO) can mediate S-nitrosation to yield
an S-nitrosothiol (RSNO). Other RNS, such as peroxynitrite
(ONOO), can also mediate S-nitration to yield S-nitrothiols
(RSNO2). Sequential oxidation of Cys thiols yields sulfenic
(–SOH), sulfinic (–SO2H), or sulfonic (–SO3H) acid deriva-
tives. Reaction of protein thiols with low-molecular weight
thiols such as glutathione can yield mixed disulfides. Alter-
natively, oxidation by ROS and RNS can result in a disulfide
bridge forming between two thiols either within a protein
chain or between protein chains. The pH sensor properties
and its propensity for modification make Cys likely to par-
ticipate in redox switches.
Modifications of Cys by ROS were first discovered in dis-
eases of oxidative stress and are also associatedwith the aging
process (90). These modifications were at first thought to be
irreversible. Diseases associated with oxidative stress include
type II diabetes, cancer, neurodegenerative diseases, and
cardiovascular disease. ROS=RNS are generated as a by-
product of metabolic processes, including aerobic respiration
inmitochondria. They are also produced byNADPHoxidases
and disgorged by macrophages during immune defense (88).
Reductive pathways that reverse the effects of ROS on Cys
were discovered by serendipity in plants. A disulfide-mediated
thiol-based redox mechanism was shown to differentially
regulate the activity of chloroplast enzymes in response to
light (31). Light generates electrons which reduce disulfides
through the ferrodoxin pathway, but disulfide reduction af-
fects the activity of different groups of enzymes in opposite
ways. Biosynthetic enzymes, such as regulated proteins in the
Calvin cycle, are activated by light. In contrast, other enzymes
such as those linked to carbohydrate degradation behave in
the opposite manner: they are inhibited by light. It was later
shown that these light-regulated pathways also respond to
ROS: a role they fulfil in bacteria, yeast, and higher organisms.
It is now understood that a continuum of redox set points
within proteins control cellular processes in response to a
range of ROS fluxes. Low fluxes mediate homeostatic control
of housekeeping redox processes while higher fluxes mount
stress and adaptive responses before a threshold is reached,
triggering apoptosis, or programmed cell death. Partial loss of
control of these processes is now believed to underlie aging
(113). Even higher levels of ROS can cause cellular necrosis.
In addition to its roles in housekeeping and the stress
response, thiol-based redox regulation is also important in de-
velopmental processes in plants and animals. In plants, thiol-
based redox regulation is involved in seed germination (31).
Inadvertent activation of proteins involved in these processes
by modern food processing techniques may contribute to the
allergenicity of seeds and nuts. In animals, the early embryo
forms under reducing conditions (93) but its environment
becomesmore oxidizing as the embryo grows (93, 116). Redox-
regulated processes govern the formation of substructures
during embryo development by selective apoptosis.
Knowledge of the relevance of these systems to health and
disease is growing exponentially, but much remains to be dis-
covered. Although the bulk of research on thiol-based redox
regulation has focused on oxidative stress, redox imbalance is
emerging as a more general disease category. A mutation in
the human aB-crystallin gene that causes a multisystem pro-
tein aggregation disease, including cardiomyopathy, was re-
cently linked to reductive stress (218). Thus, both oxidative
and reductive stress can cause disease and a more general
category of disturbances of redox homeostasis or redox imbalance
exists as a disease etiology.
Here we look at redox processes involving disulfide for-
mation with an emphasis on molecular mechanisms.
II. Types of Disulfide Switches
The molecular mechanisms underlying thiol-based redox
control are poorly defined. Students of undergraduate bio-
chemistry are still taught that formation of disulfide bonds
between Cys residues confers extra rigidity and stability to
their resident protein, forming a type of proteinaceous spot
weld, and that disulfide bonds occur in proteins in the extra-
cellular environment, but are not found in the more reducing
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environment of the cytosol. It is not uncommon for structural
biologists to routinely ascribe a role in stabilization to any
disulfide encountered, without any supporting evidence.
Redox biologists have been redefining the role of disulfides
over the last 30–40 years, but this information has still not
percolated down to undergraduate textbooks, or out of the
field of redox biology into mainstream biological research.
Disulfides are now known to form in the cytosol under con-
ditions of oxidative stress. Careful measurements of the sta-
bility of Cys mutants versus wild type show that disulfides
are not always stabilizing in their resident protein. Some
disulfides contribute little to stabilization and others may
actually destabilize their resident protein (151, 242). The
emerging paradigm is that the disulfide proteome consists of
two subproteomes: a structural group and a redox-sensitive
group (300).
How can we objectively determine whether a disulfide is
structural or redox active? The ultimate arbiter is the disulfide
redox potential. Disulfide redox potentials measured in thiol–
disulfide oxidoreductases range from 95 to 330mV (111,
145, 166, 296). For disulfides serving structural purposes, the
redox potential can be as low as 470mV (76).
We have been studying disulfides with the purpose of
distinguishing redox-active from structural disulfides. In
principle it should be possible to differentiate between the two
groups of disulfides by analysis of protein structures, and
ultimately, protein sequences.
A. Discovery of the Cross-Strand Disulfide
Our interest in the area of disulfide redox activity arose
when we first encountered a subset of unusual disulfides
during a structural data mining survey of b-sheets (290).
These disulfides, which link adjacent antiparallel strands, at-
tracted our notice because they occur in a secondary structure
that is already noncovalently linked and thus, at best, seem
redundant. Furthermore, they exhibit unusual protein ste-
reochemistry which disobeys rules expounded in classic
structural studies of disulfides by Richardson and Thornton
(224, 259).
Using an approach similar to that adopted by Ramachan-
dran to explore conformations available to the backbone of
the polypeptide chain (219), Richardson and Thornton
defined backbone protein contexts that could not form dis-
ulfides between resident Cys residues without introduction of
strain into the protein structure. They deduced four rules for
forbidden disulfide contexts. With respect to secondary
structure, disulfide bonds should not be found between Cys
pairs: on (a) adjacent b-strands (224, 259); (b) in a single helix
or strand (259); or (c) on nonadjacent strands of the same
b-sheet (259). In primary structures, disulfide bonds should
not occur (d) betweenCys pairs adjacent in the sequence (259).
An accompanying data mining study by Thornton confirmed
that in 1981 no disulfides existed in protein structures in the
Protein Data Bank (PDB) (19) that disobeyed these rules (259).
Fifteen years later, when undertaking a data mining study
to find residues that prefer each other’s company as cross-
strand partners in b-sheet, we expected ion pair-formers such
as Glu-Arg and Glu-Lys to be most favored. Indeed these
pairs are greatly enriched in b-sheets with enrichments of 3.4
compared to the frequency that would be expected based on
their abundances in b-sheet. Surprisingly however, the most
enriched pairs were Cys pairs, with enrichments in excess of
9.0. More astonishingly, some of the Cys residues were co-
valently linked to each other in direct conflict with Richardson
and Thornton’s rules. Further examination of these disulfides
showed they are extremely unusual: the disulfides and the
b-sheets around them are significantly distorted (Fig. 1).
Thus, these covalently-linked Cys pairs do not seem to fit
the paradigm of disulfides as structural stabilizers, and in
recognition of their special status we gave them a special
name: Cross-Strand Disulfides (CSDs). An independent study
of disulfide conformations performed around the same time
identified a novel disulfide conformation, dubbed the staple
conformation, not previously seen in Richardson and Thorn-
tons’ studies (92). All disulfides identified in the staple con-
formation were in fact CSDs, and we later showed that most
disulfides adopting the staple conformation are embedded in
aCSD structuralmotif (94). Harrison and Sternberg also noted
the prevalence of disulfides adopting the staple conformation
on b-hairpins (92). If these forbidden disulfides had a func-
tional rather than structural role, it seemed likely that role
would be redox-related, but there was little data to support
such a view in 1995.
Over the last 10 years, as more structures were deposited in
the PDB, more examples of forbidden disulfides came to light
(Fig. 2). Data also accumulated linking CSDs to a redox role.
In most thiol reductases, the catalytic disulfide is formed
between two Cys in a Cys-X-X-Cys motif embedded in a
thioredoxin (Trx) fold. However, solution of the structure
of the novel thiol disulfide reductase DsbD showed that it
contains a novel enzymatically-active CSD embedded in an
FIG. 1. Distortion of a b-sheet by a
resident CSD. (A) View along the
strands showing tilting of strands.
Hydrogen bonds prefer to be planar
so b-sheets should be locally flat. This
is true for the light gray reference
strands from a similar fold. The hy-
drogen bonds in the vicinity of the
CSD are not flat. (B) View from the
side showing strand tilt. CSDs also
induce shear between the involved
strands. In canonical b-sheet, the hy-
drogen bonds are perpendicular to
the strand direction. In the vicinity of
a CSD, strands are sheared to ac-
commodate the disulfide.
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immunoglobulin (Ig) fold (79). DsbD is a transmembrane
electron transporter that activates oxidized periplasmic DsbC
by reducing the active site Cys using electrons transported
from the cytoplasm. In the final step of the electron transport
process, the CSD between Cys 103 and Cys 109 in the N-
terminal domain of DsbD is reduced by the Trx-like C-
terminal domain of DsbD. The reduced form of the CSD then
specifically interacts with the oxidized form of DsbC to form
an intermolecular disulfide bond between Cys 103 of DsbD
and Cys 98 of DsbC (86). Several other CSDs form catalytic
disulfides in other enzymes, including ribonucleotide reduc-
tase and several peroxiredoxins (Prxs) (193). All of these
proteins have different folds, suggesting the CSD evolved
independently many times.
Redox activity of CSDs can also have a regulatory role in
proteins, as has been demonstrated for extracellular proteins
of the immune system. CD4 mediates cell–cell interactions in
the immune system and is the primary receptor for HIV-1.
A CSD in the second Ig domain of CD4 is reduced on the cell
surface during HIV=cell membrane fusion (181). More re-
cently, reduction of a CSD in Tissue Factor was shown to
switch the protein between its coagulation and signaling
functions (2). Examples of CSDs found in solved structures in
both redox states support the notion that this disulfidemotif is
redox active (64). These include examples in the Arabidopsis
immunophilin FKBP13.
Previous work on physical variables enhancing redox ac-
tivity suggested disulfides with high torsional energies have
an enhanced likelihood of reduction (36, 131, 279, 280, 283).
We found that CSDs are indeed associated with high tor-
sional energies and represent 8% of disulfide bonds with
torsional energies>12.5 kJmol1 in an unnormalized dataset.
Torsional energies in these early studies were estimated using
an empirical torsional energy function from the molecular
dynamics program AMBER (213). The use of this function is
not entirely satisfactory as there was no literature assessing its
accuracy. More detailed quantum chemical calculations on
the model compound diethyl disulfide subsequently showed
that it is a reasonable approximation but has several limita-
tions (95). First, it tends to underestimate most disulfide en-
ergies. More worryingly, it is unable to estimate the relative
stability of disulfide conformations accurately. Relative sta-
bility is important when assessing reaction paths in disulfide
relays and cascades. Some examples will be given in Section
IV-C. Most importantly, the AMBER torsional energy func-
tion completely fails to predict some interesting high energy
disulfide conformations. A particularly interesting feature of
the more accurate disulfide potential energy surface, not
predicted by the AMBER equation, is a high energy feature
produced by the eclipsed disulfide staple conformation (95).
CSDs sit on a medium energy ledge on this feature (Fig. 3). In
contrast, low energy hook and spiral conformations, which
are more abundant in the PDB, sit in the lowest energy wells.
These low energy disulfides are likely to be structural.
We also began to investigate the types of conformational
changes in proteins mediated by CSD redox activity. Many
CSDs join short regions of the polypeptide chain and are
commonly found bridging b-hairpins (92, 292). The location of
many CSDs on b-hairpins suggests the redox status of the
disulfide controls presentation and sequestration of epitopes
in the hairpin loop. Experimental data supporting this notion
is available for Newcastle disease virus. Antibodies against
the b-hairpin loop straddled by the CSD neutralize the fusion
protein, and two loop mutants escape neutralization (264,
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FIG. 2. CSDs in the PDB as a function of date of deposition. The increase in CSDs is likely due to selection effects such as
increased interest in redox proteins and the greater ability of crystallographers to control redox conditions during the
structure solution process.
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301). It seems likely reduction of the CSD may facilitate
opening of the head region and exposure of the fusion peptide
sequestered within the head (214). More recently, thiol=
disulfide exchange has been demonstrated to be required for
membrane fusion (121).
A beautiful structural example supporting the concept of
redox-controlled epitope presentation was recently provided
by the Arabidopsis thaliana FKBP13, a protein involved in the
immune response in plants and animals. Solved in both the
reduced and oxidized states, the hairpin loop changes its
conformation between the two redox states while the rest of
the protein remains largely static (Fig. 4) (78).
In summary, the CSD is a metastable redox-active disulfide
which occupies a medium energy ledge on a high energy
feature of the disulfide torsional potential energy surface. It
functions as a catalytic disulfide in some proteins; may me-
diate conformational changes important in protein-protein
interactions in response to redox signals, such as is likely in
FKBP; and also mediates some other functions that will be
discussed below.
B. Energetic analysis of allowed disulfide contexts
Disulfides linking Cys in adjacent b-strands, originally
postulated to be forbidden by Richardson and Thornton
clearly do exist, but they do not appear to be associated with
the original role assigned to disulfides as structural stabilizers.
Instead they appear to have a functional redox role. The
studies of Richardson and Thornton can be re-evaluated in
the light of new concepts in protein structure=function rela-
tionships.
Before the early 1990s, researchers believed that proteins
collapsed naturally into a minimally-frustrated fold during
the folding process. This concept was based on the work of
Anfinsen who showed that a protein’s amino acid sequence
determines its three-dimensional fold (5). The ‘‘thermody-
namic hypothesis’’ states that the three-dimensional structure
of a native protein in its normal physiological milieu is the one
in which the Gibb’s free energy of the system is the lowest (5).
While the general basis of this belief still holds, some new
results, such as the discovery of molecular chaperones, were
difficult to reconcile with this concept. New computational
tools, such as profiles-3D (171), originally designed as a check
on the structure solution process, showed that natural stresses
exist in proteins in functionally important regions. In addi-
tion, structural data mining studies provided evidence that
locally tolerated stresses are important for function (84, 98,
206). Although researchers were previously aware of stresses
in protein structures such as b-bulges, it was posited these
‘‘glitches’’ were temporary structural adaptations to accom-
modate insertion and deletions in the protein chain (223),
suggesting they would be refined in a later evolutionary
FIG. 3. Disulfide torsional energy surface
generated for diethyl disulfide. Structurally
stabilizing disulfides adopt low energy hook
and spiral conformations and thus sit in the
lowest energy wells on the surface, whereas
metastable disulfides such as the CSD adopts a
higher energy staple conformation and occupy
a medium energy ledge on the surface. (For
interpretation of the references to color in this
figure legend, the reader is referred to the web
version of this article at www.liebertonline.
com=ars).
FIG. 4. Conformational changes of the FK506 binding
protein in Arabidopsis thaliana associated with redox
changes of a CSD. Reduction of the CSD significantly
changes the conformation of the hairpin loop straddled by
the disulfide (top), while the rest of the protein remains lar-
gely static. The protein is active in its oxidized form. The
green structure is oxidized and red reduced. (For interpreta-
tion of the references to color in this figure legend, the reader
is referred to the web version of this article at www.
liebertonline.com=ars).
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iteration and ‘‘edited out’’. Studies on stresses in proteins
suggested the alternative view that stresses are central to the
protein’s function and conserved throughout evolution. Stress
studies also suggested that proteins do not adopt a minimally
frustrated fold. Many proteins in the PDB adopt folds that are
globally close to a minimally-frustrated fold, but contain local
tolerated stresses in functionally important regions. The result
is a protein folding funnel that does not descend to a point
corresponding to the global minimum, but instead is arrested
above this minimum energy, with a complex energy land-
scape at the bottom of the well. Many philosophers have
pondered on the physicochemical basis of life (236). From the
protein’s point of view, being ‘‘alive’’ is not being at the pointy
end of a folding funnel. Any protein that occupied the true
global minimum of its fold would be functionally dead.
As most proteins in the PDB do adopt folds close to the
global minimum, techniques such as threading can success-
fully predict three-dimensional folds. However, some pro-
teins adopt folds that are significantly different to the
minimally frustrated fold for that sequence. Proteins that
undergo large irreversible conformational changes, such as
influenza hemagglutinin, belong to this group. Redox transi-
tions, some of which are likely to be irreversible, seem also to
be fundamental to these large conformational changes (292,
293). In conclusion, it is also interesting to note that Anfinsen
observed that ‘‘proteins devoid of restrictive disulfide
bonds . . .make more convenient models for the study of
thermodynamic and kinetic aspects of the nucleation and
subsequent pathways of polypeptide chain folding’’.
C. Between-strand disulfides
At their simplest, forbidden disulfides essentially form a
bistable switch. A bistable switch requires two stable states,
both of which must contain sufficient stored potential energy
to help drive the switch into the opposite state in response to
the appropriate signal. Regions of strain in a protein structure
are candidate potential energy sources. Forbidden disulfides
may operate as bistable switches by trading off different terms
in the Gibb’s free energy (Fig. 5). Forming the disulfide bond
decreases the entropy of the chain. However, for forbidden
disulfides there is a significant enthalpic cost of forming the
disulfide because of the abnormal stereochemistry adopted by
the protein chain.
Richardson and Thorntons’ original work remains valuable
because their energetic analysis provides a basis for under-
standing disulfide switches and yields a valuable tool for
finding redox-active disulfides in protein structures. To find
other potentially redox-active disulfides, we searched for
other disulfides that, like the CSD, violate Richardson and
Thornton rules A-D (Fig. 6).
CSDs come in two flavors: antiparallel (aCSDs), which
straddle antiparallel b-strands; and more rarely, parallel
(pCSDs), which bridge parallel b-strands. aCSDs are by far
the most common type of forbidden disulfide in solved pro-
tein structures. Parallel b-sheets are less prevalent in proteins
than antiparallel b-sheets, but the rarity of pCSDs compared
to aCSDs is likely to be dictated by the more rigid strut-like
hydrogen-bonding in parallel sheets which restricts the
amount of distortion that can be accommodated in the sheet
(Fig. 7). As a result, pCSDs generally have higher torsional
energies than aCSDs with modal torsional energies of 20 and
15 kJmol1, respectively (293).
An example of a pCSD is found in Cdc25B, a phosphatase
involved in the cell cycle. In Cdc25B, the forbidden disulfide
switch acts directly to inactivate the enzyme. Oxidation of the
catalytic Cys in Cdc25B is initiated by ROS to generate a sul-
fenic acid intermediate and proceeds to the oxidized disulfide
through the glutathione buffering system (33). In the case of
Cdc25B, the reactive Cys of the redox pair, Cys 473, is also the
catalytic Cys in the phosphatase reaction, so cysteinyl modi-
fication by ROS directly inactivates the catalytic apparatus.
The low pKa of the active site Cys, which enhances its role as
the nucleophile in the catalytic reaction, also renders it liable to
attack by ROS. This suggests a general mechanism of revers-
ible inactivation of Cys-based enzymes (see Section VIII-C).
In addition to CSDs, several other types of forbidden di-
sulfide straddle adjacent b-strands and thus violate Richard-
son and Thornton’s first rule (RT rule A) (293). We refer to all
forbidden disulfides that violate rule A as ‘‘Between-Strand
Disulfides’’ (BSDs). Five previously identified types of BSD
are shown in Fig. 7.
∆G = ∆H - T∆S
A B
Folding
intermediates
Native State
Entropy
FIG. 5. Comparison of the folding
funnels for (A) a minimally frustrated
fold (B) A functional protein with two
states. In a two-state forbidden dis-
ulfide switch, the entropic term could
be traded off against the enthalpic term
to produce two states that are not sep-
arated by a large Gibb’s free energy
(light gray in B). The minimally frus-
trated fold is shown in dark gray in B for
comparison.
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The b-Diagonal Disulfide (BDD) is linked between the ith
residue in a strand and the j2 residue on the adjacent
strand, where j is the residue directly opposite i. In order to
make the covalent linkage between the two Cys residues,
the adjacent strands must adopt a high twist with respect to
each other. The BDD is somewhat rarer than the CSD. Like
the CSD, it comes in both antiparallel (aBDD) and parallel
(pBDD) varieties, with the antiparallel type being more
prevalent.
aBDDs have previously been described in several cytokine
receptors such as the erythropoietin and interleukin-10 re-
ceptors (293), as well as in botrecin, a protein from the venom
of the Brazilian viper Bothrops jararaca that mimics the binding
of von Willebrand factor to the platelet receptor, glycoprotein
Ib-IX-V, initiating thrombus formation (237, 293).
pBDDs are found in several Apo(a) and plasminogen
kringle IV domains (293). Stathakis et al. showed the homol-
ogous disulfide, Cys 461–Cys 540 in kringle V of plasmino-
gen, is reduced in the process of angiostatin production (246).
Reduction of the homologous disulfide is also implicated in
autocleavage of ovotransferrin, an iron binding protein
abundant in egg albumen that likely has an important role in
development (116).
A fifth type of disulfide that violates rule A is the b-flip
disulfide. Cys pairs in a b-flip are disulfide-linked between the
i residue in a strand and the j3 residue on the adjacent
strand, where j is the residue directly opposite i. In canonical
b-sheet, residue side-chains sequential in the polypeptide
chain decorate opposite faces of the sheet, alternating along
the strand and forming rows perpendicular to the strand di-
rection. Thus, residue i would normally only be on the same
side of the sheet as j2n residues on the adjacent strand,
where n is a counting number. In a b-flip disulfide motif, the
i and j3 residues are positioned on the same surface of the
b-sheet by the presence of two back-to-back classic bulges in
the motif (223). Thus, a b-flip contains two types of canonical
stress motifs: the forbidden disulfide and the b-bulge. Pre-
viously characterized examples of b-flips include one in
Dengue virus fusion protein and another in retinol binding
protein (293). Retinol binding protein is a carrier protein of
the lipocalin fold that transports vitamin A, in complex with
transthyretin, within the blood stream to target cells. Redl
et al. suggested that reduction of a disulfide bond in a homol-
ogous protein, human tear lipocalin, is of functional relevance
because the reduced protein shows a ninefold increase in
ligand affinity (220).
D. Other canonical forbidden disulfides
Other previously characterized canonical forbidden
disulfides that violate RT rule B-D are shown in Fig. 8. For-
bidden disulfides that violate RT rule B, that disulfides
FIG. 6. Forbidden disulfides
that disobey the Richardson–
Thornton rules of stereoche-
mistry. The RT rules specify
disulfides should not be found
between Cys pairs (A) on
adjacent strands (also called
Between-Strand Disulfides or
BSDs), (B) in a single strand
or helix; (C) on nonadjacent
strands of the same b-sheet or
(D) between consecutive Cys
in the primary sequence. Nine
different subtypes were origi-
nally identified (see (293), Figs.
7 and 8). These include five
subtypes that break RT rule
A including aCSDs, pCSDs,
aBDDs, pBDDs, and b-flips. A
sixth novel type of disulfide
that breaks RT rule A is the
End-Twist (see Figs, 10 and
15). Four other subtypes iden-
tified previously include In-
trahelical Disulfides (IHDs)
and Along Strand Disulfides
that break RT rule B, Jump
Strand Disulfides that break
RT rule C, and vicinal disul-
fides that break rule D. IHDs
are broken down here accord-
ing to the number of residues
between the two involved Cys:
i,iþ3, which conform to a CXXC motif; i,iþ4, which conform to a C3XC motif; and i,iþ5, which conform to a C4XC motif.
Examples are given. JSDs can also be subdivided into four groups depending on the strand register of the two involved Cys.
Three subtypes, i,k1, i,k2, i,k3, have been discussed previously (293). A fourth subtype which is likely to be redox active is
the i,k subtype as found in oxidized GTP hydrolase I.
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should not be found joining Cys residues within a strand or
a helix, include Inter-Helical Disulfides (IHDs) and Along-
Strand Disulfides (293). Because canonical a-helices have 3.7
residues per turn (211), Cys residues that are three or four
residues apart are nearby in the three-dimensional structure.
A previously described example of an IHD is found between
Cys 268 and Cys 272 in the R2 subunit of ribonucleotide re-
ductase (293). No redox function has as yet been ascribed to
this disulfide but the protein itself is well known for its redox
activity.
FIG. 7. Between-Strand Di-
sulfides violate RT rule A.
These include antiparallel and
parallel CSDs (I and II), anti-
parallel and parallel b-Diagonal
Disulfides (III and IV) and
b-flips (V). Examples shown
are I: Cys 435–Cys 445 in Bo-
tulinum toxin (PDB: 1epw); II:
Cys 426–Cys 473 in Cdc25B
(PDB: 1cwr); III: Cys 497–Cys
512 snake venom Botrocetin
(PDB: 1fvu); IV: Cys 2–Cys 77
in apolipoprotein A (PDB:
1i71); V: Cys 60–Cys 121 in
Dengue virus fusion protein
(PDB: 1ok8). Note the differ-
ent constraints imposed by
b-sheet backbone hydrogen
bonds on antiparallel and par-
allel forbidden disulfides. Be-
cause the hydrogen bonds are
perpendicular to strand direc-
tion, some strand shear can be
accommodated by forbidden
disulfides in antiparallel sheet
without shortening hydrogen
bonds. The strut-like configu-
ration of hydrogen bonds in
parallel b-sheet is less accom-
modating to strand shear.
pCSDs are often found on the
end of strands.
FIG. 8. Other canonical
forbidden disulfide motifs.
Along-StrandDisulfides(ASDs-
VI) and Intra-Helical disul-
fides (IHDs-VII) violate RT
rule B that a disulfide should
not be found in a single helix
or strand. Jump-Strand Di-
sulfides (JSDs-VIII) violate
rule C that a disulfide should
not be found between nonad-
jacent strands of the same
b-sheet. Vicinal disulfides (IX)
violate rule D that a disulfide
should not be found between
Cys residues adjacent in the
sequence. Examples shown
are VI: Cys 556–Cys 558 in the
human transferrin receptor
(PDB: 1de4), VII: Cys 268–Cys
272 in the E. coli ribonucleo-
tide reductase R2 subunit
(PDB: 1pj0), VIII: Cys 5–Cys 20 in human defensin (PDB: 1dfn), IX: Cys 82–Cys 83 in a fucose binding lectin of the serum of
European eel (PDB:1k12).
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Other well known redox-active disulfides that resemble
IHDs, but fail the strict criteria that both Cys, and all residues
in-between, must exhibit a-helical f, c conformations are the
catalytic disulfides in well-known thiol oxidoreductases.
These include the CXXC motif of enzymes of the Trx family
(179), and the i,iþ5 motif of the disulfide oxidoreductase
(DSOR) family (205). CXXC enzymes include Trx, glutar-
edoxin (Grx), glutathione peroxidase-like enzymes, as well as
DsbA andC (179). In these enzymes the CXXCmotif is located
at the N-terminus of an a-helix. All residues of the motif are in
a-helical conformation except the N-terminal Cys, which
adopts an N-cap position [i.e., it is hydrogen-bonded in
a-helical fashion but does not adopt helical backbone angles
(91, 225)]. The Cys in the catalytic disulfide of the DSOR
family are part of an i,iþ5 motif (CXXXXC) rather than the
i,iþ3 motif seen in Trx-like enzymes. The redox-active dis-
ulfide is close to the C-terminus of the resident helix. Both Cys,
and three of the four residues in-between, adopt helical con-
formations. The residue preceding the C-terminal Cys gen-
erally adopts a b-conformation giving the helix an appearance
of being slightly unraveled. Disulfides in both of these motifs
generally have high relative torsional energies, in excess of
10 kJmol1 above the most stable conformation. The average
relative torsional energy for the CXXC enzymes is 16.1 kJ
mol1 for a set of 51 structures with oxidized disulfides (293),
and the average for the DSOR enzymes is 22.4 kJmol1 (14
structures) (293). Thermodynamic measurements show the
disulfide bond of DsbA is so unstable in the folded state that
its stability increased by 19 kJmol1 when the protein un-
folded (303). Given the resemblance to IHDs, it is possible
these enzymes adopt higher energy disulfide conformations
as part of their catalytic cycle.
Most Along-Strand Disulfides (ASDs) are found in i,iþ2
motifs. The transferrin receptor contains a previously de-
scribed example (18, 293). Transferrin is the major iron-
transport protein in the blood. Cells requiring iron express
the transferrin receptor. Iron-laden transferrin binds to
its receptor at the cell surface and is internalized through
clathrin-coated pits into endosomes. After unloading iron,
apo-transferrin and the receptor are recycled to the cell sur-
face. Using FRET imaging, Yang et al. recently showed re-
duction of disulfide bonds in the folate receptor occurs in an
endosomal compartment (299). They were also able to dem-
onstrate co-localization of the transferrin receptor in this
compartment, and postulated similar redox activity occurs
during trafficking of the transferrin receptor. Another exam-
ple of an ASD is found in human monoamine oxidase A, an
outer mitochondrial membrane-bound flavoenzyme that
catalyzes the oxidation of the neurotransmitters serotonin,
dopamine, and norepinephrine, generating peroxide as a
byproduct. The ASD formed between residues Cys-321 and
Cys-323 is located near the entry to the catalytic site (55). Al-
though mutations of these residues did not influence catalytic
activity (294), monoamine oxidase A is known to be quite
sensitive to thiol oxidation and to thiol reagents (284), sug-
gesting the disulfide may have a regulatory role.
The Jump-Strand Disulfide ( JSD) violates RT rule C, that
disulfides should not be found joining Cys residues within
the same b-sheet. JSDs typically link Cys in the i and k2
positions where i and k indicate strands hydrogen-bonded to
opposite sides of an adjacent strand j. Linkages between i and
k, k1 or k3 are also seen. Examples include the immune
system protein defensin (293), a Cys-rich antibacterial pep-
tide that has cytolytic properties. Bjorkhem–Bergman et al.
showed mammalian Trx reductase (TrxR) alters the cytolytic
activity of the defensin-related protein granulysin, enhancing
its role in the killing of small cell lung cancer cells (23). An-
other interesting example is found in Scytovirin, a potent
antiviral lectin isolated from the cyanobacterium Scytonema
varium. Scytovirin has been reported to exhibit significant
activity against human immunodeficiency virus (198). Two
JSDs are found in the crystal structure: one between Cys 20
and Cys 32, and the other between Cys 68 and Cys 80. Each
JSD resides within one half of an internally duplicated region.
Interestingly, a disulfide connectivity different from the
crystal structure is shown by nuclear magnetic resonance and
mass spectrometry data (198), where Cys 32 & 38 and Cys 80
& 86 are paired as aCSDs, suggesting the disulfides isomerize
between the CSD and JSD linkages. Further work needs to
establish whether this is so. Finally, we recently uncovered a
link between JSDs and Zn2þ binding which will be described
in Section VI-A-2.
Vicinal disulfides, which violate RT rule D, are formed
between two adjacent Cys residues in the primary structure.
Formation of the disulfide reverses the direction of the protein
chain and distorts the peptide bond between the two Cys
residues. Carugo et al. recently reported the properties of
vicinal disulfides and reviewed data supporting redox activ-
ity for this type of forbidden disulfide (39). A vicinal disulfide
is formed as part of the reaction cycle in Drosophila melano-
gaster TrxR (130). In mammalian TrxRs (155, 305), one of the
Cys residues is replaced by amore reactive selenocysteine that
forms a vicinal selenenylsulfide during the reaction cycle.
In summary, forbidden disulfides are metastable disulfides
likely to be redox active. Like CSDs, other forbidden di-
sulfides can adopt different redox roles within proteins.
They can be: catalytic as in the Prx Bacterial Comigratory
Protein (BCP); or regulatory, controlling off-pathway events
such as in Cdc25B (33), up and down regulating protein
function, reversing reactions, or mediating protein function
through allostery. Fourteen canonical subtypes have now
been identified that disobey the Richardson–Thornton rules
of disulfide stereochemistry. A summary is shown in Fig. 6.
These classified subtypes likely represent >15% of high tor-
sional energy disulfides. In addition to the previously well-
characterized CXXC motif, forbidden disulfides represent a
canonical set of redox-active disulfides.
E. Other forbidden disulfides
In addition to the 14 canonical types of forbidden di-
sulfides reported to date, there are other disulfides that dis-
obey the RT rules, but these novel types are currently fairly
rare in solved protein structures (M. Wouters, unpublished
data). Future growth of the PDB may see this situation
change.
In addition, there are likely to be forbidden disulfides that
introduce stresses in protein structures outside the Richard-
son and Thornton canon of disulfide stereochemistry. A
possible example is found in the structure of the small Tim
protein Tim10. The small Tim family specifically mediates the
import of presequence-devoid polytopic proteins into mito-
chondria. All small Tim proteins contain a consensus twin
CX3C Zn-finger motif (141). The motif forms a hairpin-like
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structure and in the oxidized form two disulfide bonds are
nested in the sequence between Cys 40–Cys 65 and Cys 44–
Cys 61 (3). Thus, the oxidized structure looks like a pair of
tongs with two disulfides clipping it together in a closed po-
sition. When Tim 10 is translated in the cytosol, it is loaded
with Zn2þ. The role of Zn2þ-binding is to keep the protein in
its reduced, unfolded, and import-competent state in the cy-
tosol, before it is imported into mitochondria. In a low reso-
lution Tim9:10 complex (278), helical backbone angles in the
vicinity of the inner disulfide of the pair are distorted in both
Tim9 and 10, while all instances of the outer disulfide have
torsional energies exceeding 10 kJmol1 (M. Wouters, un-
published data). Thus, there is evidence of stress in the
structure around both disulfides which may contribute to
their redox activity if Zn2þ binding is reversible.
F. Folds associated with forbidden disulfides
Forbidden disulfides seem to favor some common folds.
The Trx fold is well known for its CXXC motif, which can be
considered a type of forbidden disulfide that violates RT rule
B, see Section II-D (293). But the CXXC motif is not the only
forbidden disulfide harbored by the Trx fold. Other forbidden
disulfides include CSDs in two distinct 2-Cys Prxs. Prxs have
been classified based upon the nature of the catalytic residues.
During the reaction cycle, the peroxidatic Cys attacks the
substrate, forming amixed disulfide with it. In 2-Cys Prxs, the
substrate is released by a second Cys known as the resolving
Cys, whereas in 1-Cys Prxs the substrate is released by other
means. In typical 2-Cys Prxs, the peroxidatic and resolving
Cys are located in different monomers, whereas in atypical
2-Cys Prxs the two Cys that form the disulfide are within the
same monomer. In the atypical 2-Cys Prx BCP, the catalytic
disulfide formed between the peroxidatic and resolving Cys is
an aCSD (133), whereas in the typical 2-Cys Prx from Aero-
pyrum pernix, an aCSD formed between the resolving Cys and
a 3rd Cys within the same monomer is proposed to be an off-
pathway event (193).
Previously, Martin showed that Trx, Grx, glutathione-S-
transferase, DsbA and glutathione peroxidase all share the
Trx fold (179). Three of these oxidoreductases: Trx, Grx, and
DsbA, contain the CXXCmotif. In glutathione peroxidase, the
reactive N-terminal Cys of the motif is substituted by a more
reactive selenocysteine and the C-terminal resolving Cys is
replaced by threonine. In glutathione-S-transferase both Cys
are absent, and the reaction is catalyzed by a tyrosine residue
located nearby in the aligned sequences and positioned in
three-dimensional space such that the substrate Cys residue
docks in the same relative location of the Trx fold. Despite the
differences, all these enzymes of the Trx fold interact with
substrates that possess a thiol or disulfide group and have a
common active site suggesting a common evolutionary origin
(179). Sinning et al. proposed this common ancestor was glu-
tathione binding (244). Copley et al. showed that Prxs also
evolved from a Trx-like ancestor (50). They proposed an al-
ternative classification of Prxs based on phylogenetic relat-
edness rather than reaction mechanism. Four subgroups of
Prxs (Prx1–4) were identified using eight blocks of sequence
identity, some of which are shared by several subgroups and
others that are unique to particular subgroups. Five of these
conserved blocks are also sharedwith cytochromematuration
proteins like Escherichia coliCcmG, thus providing themissing
link between Prxs and Trxs (50). In Prx1s, the C-terminal
resolving Cys of the CXXC motif is conserved but the N-
terminal Cys is replaced by Ser or Thr. A subset of Prx1s has
an additional novel Cys located five residues C-terminal to the
remaining Cys of the CXXC motif. In this subgroup, which
includes BCP, the two Cys are embedded in strands and form
an aCSD. In Prx2s the additional Cys is located in the central
insertion.
Another common fold harboring forbidden disulfides is the
immunglobulin (Ig) fold, including the related fibronectin III
domains. CSDs are found in Ig folds in theN-terminal domain
of the E. coli folding protein DsbD (79), numerous cytokine
receptors (293), immune molecules like CD4 (181), and pro-
teins that mediate cell adhesion like the E. coli pilus-forming
protein PapD (120). Evidence of redox activity is given in the
associated references. The CSDs do not occupy homologous
positions in these molecules, suggesting they evolved inde-
pendently many times.
Given the repeated independent evolution of these ele-
ments, the question arises, ‘‘Why are the same folds regularly
involved?’’ Possibly, these folds are reused because they are
associated with promoter elements that are governed by
redox-regulated transcription factors and are thus amenable
to positive selection of new redox-sensitive switches. The in-
troduction of potential disulfide-forming thiol pairs may be
facilitated by the fact that both Cys do not need to be intro-
duced in the protein chain simultaneously. Incorporation of a
single Cys may make the protein immediately responsive to a
range of oxidative modifications, including nitrosation and
glutathionylation. Introduction of a second Cys at a later stage
may then enable disulfide formation. An example where one
protein is glutathionylated and a homolog forms disulfides is
the Grx–Trx pair. Trx forms a disulfide between Cys residues
of the CXXC motif as part of its reaction cycle. Grx contains
only the reactive N-terminal Cys that is glutathionylated as
part of the reaction cycle. Another example is the 1-Cys and
2-Cys Prxs. When the resolving Cys is present, Prxs are re-
duced by Trx. When it is not, they are reduced by Grx. In this
way, protein regulation can switch from the Grx pathway to
the Trx pathway.
G. Latency in bistable switches
The latent redox state is an important consideration in the
operation of a disulfide switch. This is the state in which the
thiol pair spends most of its time under normal physiological
conditions. As a result, it is normally themost populated state,
and this is dependent on the normal redox conditions of the
cellular compartment. Comparison of the redox potentials of
thiol-pairs in proteins relative to the cellular compartment
they occupy is a means of predicting whether a disulfide
switch is latently oxidized, and would be reduced during
the switching process; or latently reduced, and oxidized dur-
ing switching. The two principal systems that maintain the
cellular thiol=disulfide redox state are the glutathione (GSH)
and Trx systems (194). These are buffered at different values
in different compartments and are dependent on cell type and
state. In the cytoplasm, the GSH=GSSG ratio is held between
260 and 200mV, whereas the Trx1=TrxR1 system is buff-
ered around the lower redox potential of 300mV. In mito-
chondria, the two systems are buffered at still lower redox
potentials, around 280 and 330mV, respectively (77). To
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understand whether a particular thiol-pair is likely to be re-
duced, oxidized or left unaffected upon perturbation of the
local redox state, its redox potential needs to be compared to
that of the relevant buffers in the cellular compartment in
question. For example, the cytosolic reductase Trx1 has a
lower redox potential (270mV) than the cytoplasm (220 to
240mV) and hence acts as a reductant in this compartment.
The redox potential of the strong oxidant DsbA is 124mV
(8, 80, 252), well above the periplasmic redox potential of
165mV (187). With regard to latent state, the cellular re-
ductant Trx1 exists predominantly in the reduced form (277),
whereas the oxidant DsbA is mostly oxidized (140).
However the latent state of these proteins should not be
confused with the ground state (Fig. 9). The folded confor-
mation adopted by the oxidized form of Trx is more stable
than the dithiol form (166), that is, the protein is poised to
return to its oxidized ground state, and like a mouse-trap,
must continually be reset into a higher energy dithiol state to
perform its function as a reductant. The opposite is true for
DsbA which prefers to be reduced (296, 303), and must con-
tinually be pumped into its oxidized state to function as an
oxidant.
As part of their normal function, redox-active disulfide
switches undergo transient switching away from their latent
states. However, the latent redox state of switches can be
perturbed through modification of the buffered redox po-
tential or disruption of the redox homeostasis system. Thiol
oxidoreductases are not true catalysts. A true catalyst is un-
changed by its reaction, whereas thiol oxidoreductases need
an additional helper molecule to return to their latent state.
Thus, the entire system acts as a catalyst rather than an indi-
vidual protein. This is not the case for other oxidoreductases
that transfer an electron from a cofactor to a substrate. Pro-
blems are caused in these systems by removal of components
of the electron chain. For example, an E. coli strain lacking the
enzyme TrxR is no longer able to regenerate Trx1 and 2, and
the cells accumulate the oxidized forms of both (247). Simi-
larly, in an E. coli strain lacking DsbD, DsbC is found in the
fully oxidized state (226).
1. Latently reduced switches. Latently reduced switches
(dithiols) occupy reducing compartments such as the cyto-
plasm. Disulfides can form in the cytoplasm under conditions
of oxidative stress, which leads to a more oxidizing (positive)
cell redox potential; or in response to localized generation of
ROS. The latter process is likely to be important for normal
tissue function both during development and in the adult
organism. Different levels of ROS induce specific cellular
processes. In general, low levels of ROSmodulate homeostatic
switches in proteins. Moderate levels are mitogenic or pro-
mote differentiation. Higher amounts of ROS favor growth
arrest, while even higher concentrations activate apoptosis.
Thus, the thresholds within proteins that effect these path-
ways must be set at appropriate levels so that the correct
pathways are activated once a particular level of ROS is
achieved. Excessive amounts of ROS cause necrosis.
Diurnal regulation of plant enzymes in response to varying
light levels is the archetypal example of a homeostatic re-
sponse (31). Adaptive responses include the activation of
transcription factors. In bacteria such as E. coli, the tran-
scription factor OxyR mediates transcription in response to
oxidative stress by binding to *30 target genes. The yeast
protein Yap1 performs an analogous role in eukaryotes. The
formation of disulfides is transient and may be reversed by
proteinaceous reductants such as Trx or by glutathione.
Oxidative stress responses are likely to be maladaptive
when continually stimulated in diseases such asmotor neuron
disease, Alzheimer’s disease, diabetes, heart disease, aging,
and possibly graying of hair (7), where degeneration of the
oxidative control processes is implicated. Finally, very high
levels of ROS can induce apoptosis. This may be maladaptive
but can also be an important programmed event during de-
velopment. Selective apoptosis mediated by hydrogen per-
oxide governs the formation of substructures during embryo
development (97). Expression and regulation of antioxidant
enzymes in the developing limb suggest ROS mediates in-
terdigital cell death (235). Motoneuronal death during spinal
cord development is mediated by oxidative stress (233).
2. Latently oxidized switches. Latently oxidized switches
are generally found in oxidizing compartments such as the
endoplasmic reticulum (ER) and extracellular compartments.
Reduction, or possibly isomerization, of disulfide bonds is
important for transient switching in these compartments.
FIG. 9. Potential energy wells
showing the latent and ground
states of DsbA (left) and Trx
(right). The oxidized form is sha-
ded light gray and the reduced
form dark gray.
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Processes such as blood coagulation and development are
likely to be dependent on transient switching of latently oxi-
dized disulfide switches. In the case of membrane-resident
proteins such as receptors and ion channels, redox regulation
of disulfides on the extracellular surface may mediate signal
transduction from the outside to the inside of the cell. A redox-
active disulfide in cell surface Tissue Factor can switch the
protein’s function between coagulation and cell signaling (2).
Research in this area is still in its infancy.
Factors influencing the reduction of latently oxidized
switches include mechanical force such as twisting and str-
etching, as well as exposure to reducing agents. The ratio of
[GSSG] to [GSH] is higher in oxidizing compartments: in the
ER*1:1–3 compared to 1:30–100 in the cytosol, resulting in a
redox potential of 230mV. GSH reduces protein disulfide
isomerase (PDI) and secretory proteins, allowing isomeriza-
tion of disulfide bonds. Reduced thiol groups in PDI interact
with ERO1p to be reoxidized. The ER is highly enriched with
PDIs but it is generally assumed their action in the ER is
confined to protein folding. This view is being modified by
work such as that by Park et al. (208) which recently showed
that PDI-mediated redox activity of the a2 disulfide of the
MHC I complex optimizes peptide-binding in the groove by
ejecting nonoptimal peptides. PDI’s involvement in peptide
loading is probably more accurately described as protein as-
sembly than protein folding. The ER contains a plethora of
PDI-like proteins whose exact functions have not yet been
determined.
In the extracellular environment, Trx and PDIs have been
shown to act as reductants. Trx is generally perceived as a
cytosolic protein, but is also actively secreted by a variety of
normal cells, including fibroblasts, airway epithelial cells,
activated B and T lymphocytes, as well as transformed cells
(57, 229). In addition, PDIs, like Trx, are found outside the ER
and have been shown tomodulate cytokine receptor signaling
(2). Formation of a complex with the substrate via a mixed
disulfide seems to occur.
The population of latently oxidized switches is perturbed
under conditions of reductive stress. Reductive stress in the
ER prevents formation of disulfide bonds and leads to an
unfolded protein response (14). Hypoxia and the forced pro-
duction of thiol-rich secretory proteins are postulated as
principal causes of ER reductive stress. Reductive stress
can also be maladaptive. The autosomal dominant R120G
mutation in the human aB-crystallin gene causes a multi-
system, protein aggregation disease including cardio-
myopathy. Transgenic mice overexpressing cardiac-specific
hR120GCryAB had a cardiomyopathy phenotype and were
found to be suffering reductive stress. The redox potential of
the glutathione buffering system is altered in the myopathic
hearts. Increased recycling of glutathione from its oxidized
form to its reduced state by augmented expression and en-
zymatic activities of glucose-6-phosphate dehydrogenase,
glutathione reductase, and glutathione peroxidase was re-
sponsible (218).
III. Determinants of the Redox Potential
A. Role of primary structure in determining
the redox potential
Experiments to determine how the redox potential of a
dithiol pair is encoded in a resident protein have most ex-
tensively studied the CXXC motif embedded in the Trx fold.
Evolutionary adjustment of the redox potential of the CXXC
motif is quite remarkable: measured redox potentials for
the CXXC motif in E. coli range from 287mV for EcTrx to
95mV for DsbL, a dynamic range of 182mV (Table 1). The
CXXC motif was originally characterized as a latently-
reduced switch. However, its frequent appearance in
isomerases and its later characterization as an oxidant dem-
onstrates its versatility and it has been described, in an evo-
lutionary sense, as a molecular rheostat (43). The molecular
basis of this variability has been extensively studied. The lo-
cation of the CXXC motif at the N-terminus of a helix was
proposed to contribute to the extremely low pKa of the reac-
tive Cys via the helix dipole effect (144). The internal XX se-
quence is an important determinant of the disulfide redox
potential (111). The effects of changing the XX residues in Trx
and DsbA are opposite (195, 196). Trx becomes a less potent
reductant, but DsbA becomes a less potent oxidant, suggest-
ing the two oxidoreductases represent the extremes to which
the redox potential motif can be tweaked by manipulation of
the internal sequence. Within the same context, the redox
potential is a function of the pKa of the catalytic Cys (80).
However, the redox potential is not solely determined by the
pKa and is also a function of pH-independent factors (43).
These include the dihedral strain energy and othermechanical
aspects of the polypeptide chain such as entropic factors.
Although the structures of many thiol oxidoreductases
have been solved in both oxidized and reduced forms, the
dynamics of their reactions are hidden from us. The reaction
mechanics are likely important determinants of the redox
potential (286). Two steps in the reaction need to be consid-
ered: formation of the mixed disulfide accompanied by the
first electron transfer; and resolution of the mixed disulfide
accompanied by the second electron transfer. We need to
dissect how mechanical and electrostatic effects contribute to
each of these steps. In a protein that is latently oxidized, stress
in the disulfide, which is increased by twisting or stretching
upon encountering the substrate, should facilitate formation
of the mixed disulfide. For example, the first residue of the
XX sequence in both Grx and DsbA is proline, a residue
conformationally-restricted by its ring structure to a greater
extent than any of the other 18 amino acids with sidechains.
The residue preceding proline is also sterically restricted in
any polypeptide chain and this residue is the catalytic Cys in
both these oxidoreductases. The most reducing DsbA mutant
with a Pro–Pro sequence (80), has an extremely restricted
conformational space. Entropic factors may also be important.
For a latently reduced protein, conformational freedom of the
active site thiols may favor its interaction with the more
conformationally-restricted thiol in its substrate. The XX res-
idues in E. coli Trx also include a proline, but in the second
position, in which it only marginally modifies the large con-
formational space available to the sidechain-less glycine in the
first position. In addition to these purely mechanical consid-
erations, the electrostatic environment and its dynamics are
important. Many of the CXXC oxidoreductases of the Trx fold
have a histidine residue in the first or second position that
likely stabilizes the nearby Cys residue as a thiolate (75). How-
ever, the internal residues are not the only important deter-
minants of the redox potential. The internal residues of Grx1
and 3 are the same (PY) but the redox potentials differ by 35
mV, giving some measure of the influence of other variables.
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Similar internal residue preferences are apparent in
ferrodoxin-thioredoxin reductase (FTR), the disulfide-reducing
protein of chloroplasts. Several of the Cys ligands of the
redox-active iron center are embedded in CXC motifs which
feature internal Pro and His residues. The C55PC57 and
C85HC87 sequences each donate their N-terminal Cys as li-
gands to the 4Fe–4S center, with the C74PC76 sequence do-
nating the other two ligands. In the latent state, a disulfide is
formed between the two free Cys, 57 and 87. In the C55PC57
motif, the peptide bond between the conformationally-
restricted Pro residue and the mixed disulfide-forming C-
terminal thiol adopts a higher energy cis conformation. After
activation by receiving electrons from ferrodoxin, the disul-
fide is reduced and Cys 87 penta-coordinates the [4Fe–4S]
cluster. In the first step of the reaction, Cys 57 forms a mixed
disulfide with Trx to form the one-electron reaction interme-
diate. In the second half of the reaction, His 86 of the CHC
motif moves towards the Fe–S cluster in response to the ad-
ditional positive charge on the cluster, detaching the fifth Cys
ligand.
Table 1. Redox Potentials Associated with Particular Structural Motifs
Protein Disulfide RP (mV) Ref. Compartment Function disulfide Function protein
CSD redox potentials
EcDsbDa 104–110 2292,232{ 46, 228 periplasma catalytic folding
PtPrxQ
}
108–113 325{ 227 chloroplastb catalytic antioxidant
CXXC motif redox potentials
EcDsbL 29–32 95§ 82 periplasma catalytic oxidizes arylsulfate
sulfotransferase
EcDsbA 30–33 122§ 111 periplasma catalytic folding E. coli
EcDsbB 41–44 69§ 81 periplasma catalytic folding E. coli
EcDsbB 41–44 207{,271{ 118, 221 periplasma catalytic folding E. coli
EcDsbG 126–129 126§,129§ 21, 272 periplasma catalytic folding E. coli
EcDsbC 98–101 140§ 228 periplasma catalytic folding E. coli
ScErv1 130–133 150§ 52 IMSc catalytic folding yeast
MmERp16 66–69 165§ 125 ERd catalytic folding
ScPDI-a 61–64 188 287 ERd catalytic folding
ScPDI-a’ 406–409 152 287 ERd catalytic folding
EcGrx3 12–15 1983 8 cytoplasme catalytic redox homeostasis
BjCcmG 92–95 209,217§ 60 periplasma catalytic folding E. coli
EcTrx2 73–76 2214 87 cytoplasme catalytic redox homeostasis
NmPilB 67–70 2272,232§ 295 cytoplasm,
fimbrium
catalytic redox homeostasis
EcGrx1 11–14 2333 8 cytoplasme catalytic redox homeostasis
EcDsbDg 461–464 2412,235{ 46, 228 periplasma catalytic folding E. coli
BsResA 74–77 256{ 162 periplasma catalytic cyt c maturation
PfTrx 30–33 270^ 129 cytoplasme catalytic redox homeostasis
PfTrx 30–33 2728 42 cytoplasme catalytic redox homeostasis
DmTrx2 40–43 2758 42 cytoplasme catalytic redox homeostasis
EcTrx 33–36 2848 42 cytoplasme catalytic redox homeostasis
SoTrx-m 37–40 282{ 197 chloroplastb catalytic redox homeostasis
SoTrx-f 46–49 291{ 197 chloroplastb catalytic redox homeostasis
HsTrx2 90–93 330{ 134 MMf catalytic redox homeostasis
Other redox potentials
PaMexR 30–62* 155§ 41 cytoplasme regulatory transcription
repressor
StAhpC 47–166 1781 209 cytoplasme catalytic antioxidant
EcOxyR 199–208 185§ 9 cytoplasme regulatory oxidative stress
response
EcDsbB 104–130 186§ 81 periplasma catalytic folding E. coli
EcDsbB 104–130 250{,284{ 118, 221 periplasma catalytic folding E. coli
ScMia40 53–55 200§ 13 IMSc catalytic folding IMS
CeOOC-5 287–329 210§ 306 ERd regulatory regulates trafficking
Hv2-Cys Prx 64–185 315{ 142 chloroplastb catalytic antioxidant
SoFTR 55–57 320{ 101 chloroplastb catalytic redox homeostasis
Protein column: }CSD status based on homology to BCP. Disulfide column: *interchain disulfide; Redox Potential (RP) column: Method
equilibrated against {DTT, §GSSG=GSH, {cysteine=cystine, 8NAD=NADH, ^NADP=NADPH. Numerical superscripts equilibrated against
substrate, Key: 1-Grx1; 2-Trx, 3-TrxPDI, 4-DsbDg. Redox potentials of compartments are indicated as superscripts, Key:
aperiplasm 165mV
(187); bchloroplast 330mV<x<280mV (209); cIMS 255mV (109); dER 180mV (115); ecytoplasm 232mV (115); fMM mitochondrial
matrix 280mV (134). Abbreviations: species: Bj, Bradyrhizobium japonicum; Bs, Bacillus subtilis; Ce, Caenorhabditis elegans; Ec, E. coli; Hs, Homo
sapiens; Hv, Hordeum vulgare; Mm, Mus musculus; Nm, Neisseria meningitides; Pa, Pseudomonas aeruginosa; Pf, Plasmodium falciparum; Pt, Populus
tremula; Sc, Saccharomyces cerevisiae; So, Spinacia oleracea; St, Salmonella typhurium; cyt c, cytochrome c; other abbreviations: IMS,
intermembrane space, MM, mitochondrial matrix.
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The redox potentials of other forbidden disulfides in which
the involved thiols are near each other in primary structure
are also likely to be greatly influenced by the internal and
flanking residues. These forbidden disulfides include IHDs
such as CXXC motifs and the i,iþ5 motifs in DSOR thiol
oxidoreductases, as well as ASDs and vicinal disulfides.
B. Role of secondary structure in determining
redox potential
For other forbidden disulfides, where the involved Cys are
further separated in the sequence, secondary structure seems
to play amajor role in determining the latent state of the redox
switches. In crystal structures, antiparallel CSDs are com-
monly oxidized while parallel CSDs are more often found
reduced, suggesting the two types of CSDmay favor different
latent states. The two types of CSD also tend to occupy dif-
ferent cellular compartments. Many proteins containing
pCSDs are cytosolic and thus likely to spend most of their
time in the reduced state. Three pCSDs identified to date func-
tion in the cell cycle: a process known to be redox-regulated
(33, 49). These include the eukaryotic cell cycle regulator
Cdc25 phosphatase (33), and two enzymes involved in pep-
tidoglycan synthesis in E. coli: glmU and murD (20, 30, 94).
Thus, there seems to be a loose relationship between the for-
bidden disulfide motif, the cellular compartment, and the la-
tent state of the switch (94).
Redox potentials of CSDs measured to date range from
229 to 325mV (Table 1), but the data are very limited. Thus,
there is overlap between known redox potentials of the
CXXCmotifs in the Trx fold and CSDs. It has previously been
observed that the flow of electrons in redox pathways alter-
nate between proteins of the Trx fold and proteins of other
folds, or from a disulfide perspective, that CXXC motifs al-
ternate with disulfides arranged otherwise. The CSD is an
example of a disulfide arranged otherwise. One example is the
DsbDpathway. The disulfide formed between Cys residues in
the CXXC motif of the Trx-like DsbC is a substrate of thiols
which form the aCSD in the Ig-like N-terminal domain of
DsbD, and this in turn is reduced by the CXXC motif in Trx-
like C-terminal domain of DsbD. Another example is the CSD
in PrxQ, which is a known substrate of Trx y (47).
C. Influence of conformational changes
and measurement technique
Disulfide torsional energies and hence redox potentials are
dependent on the conformation adopted by the cystine.
Redox-potentials may change upon docking a ligand. An
example is the OOC-5 protein from the Torsin-family
AAAþwhich contains a critical disulfide adjacent to sensor-II
that couples redox state to nucleotide binding. The equilib-
rium redox potential of OOC-5 is 210mV in the absence of
nucleotide. However, when ADP was present, the redox po-
tential decreased from 210mV to less than 240mV (306).
In the absence of nucleotide the redox potential of OOC-5 is
very close to that of the lumen of the ER under normal con-
ditions, enabling it to respond to the changes in ER redox
state. It has been proposed that the Torsin-family AAAþ
OOC-5 functions during oocyte or early embryo development
as an integrator of redox and nucleotide concentrations: two
key parameters reflecting the metabolic status of the cell.
For proteins where conformational changes affect disulfide
redox potential, the measured redox potential may be de-
pendent on the measurement technique. Two methods com-
monly used to determine redox potentials are titration against
small molecular weight compounds such as DTT and
GSH=GSSG, and equilibration between proteins (8). For pro-
teins where large conformational changes occur in the reac-
tionmechanism, the protein equilibrationmethod should give
more accurate results than titration against small molecular
weight compounds. However, this may only be true if the
wild-type redox couple is used. This might explain large
discrepancies in redox potentials measured for proteins like
DsbB (Table 1).
Measurement of disulfide redox potentials is complicated
further if disulfide cascades are involved, as is the case for
DsbB and Ero1. These additional disulfides may act as step-
down transformers between the redox potential of the in-
organic molecule and the substrate. A similar principle has
recently been demonstrated for the [4Fe–4S]2þ=3þ redox
couple of FTR. The redox potentials of both the [4Fe–
4S]2þ=1þ=[4Fe–4S]2þ=3þ couples of the [4Fe–4S] cluster differ
substantially from those of the electron donor ferrodoxin
and the electron acceptor Trx. An additional Cys residue
(Cys 87), which transiently forms a penta-coordinated in-
termediate, lowers the redox potential of the [4Fe–4S]2þ=3þ
redox couple from þ420 to 210mV, close to the redox po-
tential of the Trx active-site disulfide (53). It is likely a sim-
ilar mechanism operates for the electron transfer between
ferrodoxin and the [4Fe–4S]2þ=1þ redox couple of FTR. Al-
ternatively, intraprotein disulfide isomerization has been
proposed to act as a kinetic driver of thermodynamically
unfavored reactions (127). The redox potential of DsbA
(124mV) is higher than the redox potential of the 104–130
disulfide of DsbB (186mV). After formation of the mixed
disulfide between Cys 30 of DsbA and Cys 104 of DsbB,
intraprotein electron transfer by reduction of the 41–44 bond
of DsbB has been proposed to occur faster than the inter-
protein reverse reaction of reduction of the DsbA disulfide.
Finally, it is possible that the redox potentials of DsbB have
still not been accurately measured. If the redox potentials of
the disulfides being measured are dependent on activated
states of the other disulfides in the system, measurement of
the redox potentials of single disulfide mutants (81, 221) may
not give accurate results.
IV. Switching of Redox-Active Disulfides
The modes by which redox-active disulfides are reduced
are slowly being established. Stretching and twisting of the
bond can enhance reduction. For example, DTT-mediated
reduction of disulfides can be accelerated by applying an
external stretching force to the bond (285). However, apply-
ing a similar external force to Trx lessened its ability to
reduce disulfide bonds (286). Within the context of a thiol-
oxidoreductase the force must be applied discriminately so
that it aids and does not hinder the mechanics of the reaction.
Different mechanismswill be in competition for a nucleophilic
addition on the disulfide. Depending on the angle of attack, an
SN2 reaction may be favored over disulfide-thiolate exchange
(11, 12).
Little is known about formation of forbidden disulfides
during folding or function. Given that forbidden disulfides
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store energy in their protein chains, it seems unlikely they
would form spontaneously in a fully-folded protein. We
speculate they are regenerated by an oxidase as part of the
dithiol=disulfide cycle. The scant evidence available points to
a role for Trx-like proteins in oxidation. The aCSD in the ox-
idoreductase DsbD is oxidized by its substrates DsbC, DsbG,
and CcmG (132). The aCSD-containing molecular chaperone
PapD in E. colimediates pilus assembly, but is unable to do so
in a DsbA negative background (120).
Within a protein, autoreduction of a disulfide is possible if a
conformational change brings amore reactive Cys or disulfide
within proximity. Autocatalysis is also possible if a basic
residue such as Lys or Arg is brought into the vicinity of a
redox-active disulfide by a conformational change. Thismight
be the case for integrin which has been demonstrated to have
endogenous disulfide isomerase activity.
A. Cellular transport as a switching mechanism
Because different cellular compartments are buffered at
different redox potentials, transfer of a protein from one
compartment to anothermay be sufficient to reduce or oxidize
disulfides. Cellular transport has already been demonstrated
to be important in thiol-based redox switching for proteins
entering endosomes. Using FRET imaging, Yang et al. recently
showed that reduction of disulfide bonds in the folate receptor
occurs in an endosomal compartment (299). They were also
able to demonstrate co-localization of the transferrin receptor
in this compartment and postulated that similar redox activity
occurs during trafficking of the transferrin receptor. A num-
ber of proteins containing forbidden disulfides including the
transferrin receptor, retinol-binding protein, and numerous
viral and bacterial cell proteins are trafficked through endo-
somes. Disulfides in viral and bacterial cell entry proteins
likely co-opt the change in redox environment that occurs
upon transit between cellular compartments as part of their
cell entry strategy (292, 299).
In eukaryotes, nucleocytoplasmic transport is also impli-
cated in disulfide switching. Early work suggested alternate
mechanisms exist in bacteria and eukaryotes for control of
transcription factors mediating the oxidative stress response.
In E. coli, formation of disulfides in OxyR controls the oligo-
meric state of the protein, and thus its DNA-binding activity.
In yeast, DNA binding by the analogous transcription factor
Yap1 is not affected by oxidation (148). Instead Yap1 regulates
the oxidative stress response via a completely different mode
involving nucleocytoplasmic transport. Upon cytoplasmic
oxidative stress, an intramolecular disulfide is formed mask-
ing a nuclear export signal. Upon the basis of these experi-
ments, it was postulated that bacterial redox mechanisms
work directly to regulate proteins, whereas in eukaryotes
nucleocytoplasmic transport is used to control transcription
factors instead. Given that other eukaryotic proteins have
been shown to be directly redox regulated (123), it seems
unlikely that eukaryotic transcription factors should be ex-
empt from this direct mode of redox control. Both mecha-
nismswere later shown to control the eukaryotic transcription
factor Hmgb1 demonstrating both mechanisms are utilized in
eukaryotes (106), a far more likely scenario from an evolu-
tionary point of view. Thus, nucleocytoplasmic transport is an
additional mode of redox control that has been added in eu-
karyotes.
B. Redox gradients at the organismal level
At the organismal level, temporal transitions of redox
conditions which occur during mammalian embryonic de-
velopment are related to the gradient of redox conditions that
exist along the oviduct. Pre-implantation, the fertilized egg
encounters increasingly more reducing conditions as it travels
down the oviduct (93). Embryonic substructures are formed
by a ROS-mediated program of apoptosis. Cell death activa-
tion during cavitation of embryoid bodies is mediated by
hydrogen peroxide. Expression and regulation of antioxidant
enzymes in the developing limb support a function of ROS in
interdigital cell death (235). Motoneuronal death during spi-
nal cord development is also mediated by oxidative stress
(233).
C. Disulfide relays and cascades
Disulfide switches may have different set points allowing
electron transfer through disulfide cascades. These cascades
may occur either between proteins, as occurs in the Dsb
folding pathways, or within a single protein, as occurs in
S. aureusArsC. In all cases, the redox potential of the substrate
must be higher than the electron donor so that a downhill flow
of electrons occur. However, because redox potentials are
dependent on the conformation of the disulfide, conforma-
tional changes of the protein can enable these cascades within
a single protein. In addition, apparent ‘‘uphill’’ transfer of
electrons may occur if a disulfide redox potential is ligand-
dependent. However these proteins are not perpetual motion
machines and the protein needs to be reset for the next cycle
by the addition of energy through an exogenous factor. Al-
though the term ‘‘cascade’’ is used for both intra- and inter-
protein electron transfers to indicate the downhill flow of
electrons, we reserve the term in the following discussion for
intraprotein transfers and use ‘‘relay’’ for interprotein electron
transfers.
1. Disulfide relays. Because thiol oxidoreductases are not
true catalysts, their reactions must proceed through disulfide
relays. The Trx buffering system is well known. In bacteria
and animals, Trx is reduced by TrxR with electrons donated
by NADPH=NADH, while in chloroplasts of plants, Trx is
reduced by FTR with electrons donated by ferrodoxin. An-
other well-known example of an interprotein cascade occurs
in the Dsb folding pathways in E. coli. As previously noted,
alternation occurs between CXXC motifs and disulfides ar-
ranged otherwise. In the DsbD pathway this alternation
proceeds from a CXXC motif (DsbDg) to an aCSD (DsbDa)
back to a CXXC motif (DsbC=G).
2. Disulfide cascades. Well known examples of in-
traprotein disulfide cascades occur during the reactions of
ribonucleotide reductase and thioredoxin reductase. In the
class I ribonucleotide reductase of E. coli, a disulfide is first
formed between Cys 225 and Cys 462 in the active site. Thiol–
disulfide exchange transfers electrons to a disulfide on the
surface of the protein between Cys 754 and Cys 759 which is
ultimately reduced by Trx or Grx.
Another example of an intraprotein cascade occurs in Sta-
phylococcus aureus arsenate reductase, in which stepwise for-
mation of the Cys 10–Cys 82 and Cys 82–Cys 89 disulfides
form part of the reaction cycle to detoxify arsenic (186). Upon
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activation, a forbidden BSD forms between Cys 10 and Cys 82
that conforms to an End-Twist motif (N. Haworth, unpub-
lished results). It initially likely adopts the lower energy
conformation present in chain A of the structure (Fig. 10) with
a relative torsional energy of 14.9 kJmol1 (95). Recondensa-
tion of additional helical structure at the N-terminus of the
helix comprising residues 82 to 97 likely twists the carboxylate
of Cys 82 into the higher energy disulfide conformation found
in chain B with a relative torsional energy of 24.0 kJmol1,
rendering it susceptible to attack by the nearby Cys 89 thio-
late. The subsequently formed Cys 82–Cys 89 disulfide adopts
a conformation with a lower energy of 12.2 kJmol1, and is
sufficiently stable that it must be reduced by Trx in order to
regenerate arsenate reductase for the next reaction cycle.
An example of a protein containing multiple disulfide
switches which may communicate by allostery is the sarco-
plasmic reticulum calcium pump SERCA. SERCA1a pumps
Ca2þ from the cytosol of skeletal muscle cells into the sarco-
plasmic reticulum store: terminating the process of muscle
contraction. Four key states in the reaction cycle have been
structurally characterized (Fig. 11). In the Ca2þ-binding E1
state both disulfides are reduced. In the E2P state in which
Ca2þ is released into the lumen, a low torsional energy dis-
ulfide (*8 kJmol1) is formed on the lumenal side of mem-
brane between Cys 876 and Cys 888 (Fig. 11). In the E2P* state,
a second disulfide is formed between Cys 636 and Cys 675 in
the cytosol. In this state, the torsional energy of the Cys 876–
Cys 888 disulfide increases. Both E2P* disulfides have ex-
tremely high torsional energies of *40 kJmol1. Disulfides
with such high energies may be reduced mechanically with-
out the aid of an exogenous reducing agent or reductase. On
transiting to the E2 state, the Cys 636–Cys 675 disulfide is
reduced and the torsional energy of the Cys 876–Cys 888
disulfide decreases to*25 kJmol1.
It is unclear whether these disulfides are physiologic and if
so, part of the reaction cycle or off-pathway events. Redox
regulation has been demonstrated for the homologous protein
SERCA 2b which is expressed in all tissues at low levels.
Previous work showed ERp57 modulates the redox state of
ER-facing thiols in SERCA 2b in a Ca2þ-dependent manner,
providing dynamic control of ER Ca2þ homeostasis (164). In
addition, Cys 674, homologous to Cys 675 in SERCA1a, can be
glutathionylated following modification by NO, and Cys 674
and Cys 875, are sulfonated in atherosclerosis.
3. Ramping and alternate pathways. It has been pro-
posed that some thiol-based switchesmay bemultistate rather
than simple binary (ON=OFF) switches. Disulfide formation
may only be one option of an alternate pathway, ormay be the
ultimate step in discrete ramping of oxidation (204). For the
redox-sensitive transcription factor, OxyR, formation of a
disulfide between Cys 199 and Cys 208 is only one potential
modification. Cys 199 can be differentially oxidized depend-
ing on the extent of redox imbalance and the nature of the
oxidizing molecules. Kim et al. showed S-hydroxylation,
S-nitrosation, or S-glutathionylation of Cys 199 could produce
discrete outcomes of gene expression in vivo. Alternate mod-
ifications of the Cys residue differentially affect DNA binding
which is dependent on cooperative effects between OxyR
subunits (136).
FIG. 10. Intraprotein disulfide
cascade in ArsC. The latent state
with three free thiols is shown in
green (PDB: 1jf8). The first disulfide
intermediate between Cys 10 and
Cys 82 shown in blue and pink is
trapped as a short-lived high energy
intermediate in the crystal structure
of the Cys89Leu mutant (PDB: 1lk0).
The disulfide is embedded in an
End-Twist motif and adopts two
different conformations in the crys-
tal structure. The higher energy con-
formation ( pink) aligns the sulfur of
Cys 82 with the nearby thiolate of
Cys 89. The second disulfide inter-
mediate between Cys 82 and Cys 89
shown in yellow is trapped in the
Cys10 mutant (PDB: 1lju). The sec-
ond disulfide intermediate is re-
duced by Trx to return the protein to
the latent state. (For interpretation of
the references to color in this figure
legend, the reader is referred to the
web version of this article at www.
liebertonline.com=ars).
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D. Irreversible redox switches
In addition to the latency of the switch, another important
variable is the frequency of use. Switches can be reversible or
single-use switches. Conformational constraints imposed by
primary and secondary structure influence the reversibility of
the redox switch. For some forbidden disulfide types, the
primary structure of the polypeptide chain provides a basic
constraint on the conformational space that must be searched
in order to reoxidize the reduced thiol pair. These include
CXXC motifs, CXC motifs such as those found in ASDs, and
vicinal disulfides (CC motif ). Forbidden disulfide motifs as-
sociated with ordered secondary structures may provide ad-
ditional constraint on the polypeptide chain. For example, the
CXXCmotif in a helical context is additionally constrained by
the hydrogen bonds of the helix. The majority of CSDs which
straddle b-hairpins covalently link Cys residues which are
nearby in sequence. On the other hand, when disulfides are
formed between Cys residues distal in the primary structure,
the polypeptide chain provides little constraint. Long-range
forbidden disulfides rely more on their context secondary
structures for stability. If these constraints are of low energy,
for example, constituting only a few hydrogen bonds, their
disruption may cause an irreversible conformational change
in the protein. By this we mean that without the help of
folding chaperones, it is improbable the protein could attain
its former conformational state.
Common traits associated with proteins that undergo ir-
reversible redox-controlled conformation changes are the
long range nature of the covalent linkages involved and
cleavage of the polypeptide chain. Nicking of the chain may
increase the redox potential by increasing the entropy of the
chain (292). An example is the activationmechanism ofmatrix
metalloproteases. Matrix metalloproteases are synthesized as
zymogens. The pro-peptide contains a Cys ligand which
contributes to tetrahedral coordination of Zn2þ. Upon cleav-
age of the pro-peptide, the resident Cys ligand releases its
hold on the Zn2þ and is replaced by water, activating the
enzyme.
Viral entry proteins contain both long-range forbidden
disulfides, likely to be irreversible, associated with cleavage
sites; and short-range forbidden disulfides, such as those on
b-hairpins, which are likely to be reversible.What drives these
large irreversible conformational changes?Work on influenza
hemagglutinin provides some illumination. Influenza A
hemagglutinin (HA) is expressed as a single chain. During
transit from the ER, the polypeptide chain is cleaved in two.
The cleavage site is straddled by a forbidden disulfide be-
tween Cys A4 and Cys A466 (B137 after HA cleavage). The
two halves of the polypeptide chain are linked only by the
single covalent bond of the forbidden disulfide after cleavage.
The two-chain HA is in ametastable state until it is exposed to
low pH, whereupon the smaller C-terminal chain spontane-
ously adopts a new conformation (34). It appears, therefore,
FIG. 11. Intraprotein di-
sulfide formation in SERCA.
The forward mode where
Ca2þ is pumped from the
cytosol to the SR store is in-
dicated by arrows. In the Ca2þ-
binding E1 state (cyan) both
disulfides are reduced (PDB:
3ba6). In the E2P state ( pink)
in which Ca2þ is released into
the lumen, a low torsional en-
ergy disulfide (*8 kJmol1) is
formed on the lumenal side of
the membrane (circled in red,
PDB: 3b9b). In the E2P* state
(yellow) a second disulfide is
formed in the cytosol between
Cys 636 and Cys 675 and the
torsional energy of the Cys
876–Cys 888 disulfide in-
creases (PDB: 3b9r). Both E2P*
disulfides have very high tor-
sional energies of*40kJmol1.
On transiting to the E2 state,
the Cys 636–Cys 675 disulfide
is reduced and the torsional
energy of the Cys 876–Cys
888 disulfide decreases to
*25 kJmol1 (PDB: 2eau). (For
interpretation of the references
to color in this figure legend,
the reader is referred to the
web version of this article at
www.liebertonline.com=ars).
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that during folding, the larger N-terminal chain kinetically
traps the C-terminal chain in a non-native fold. Exposure to
low pH tips the balance in favor of the native fold which is
adopted spontaneously. This scenario is supported by the
observation that the smaller chain adopts the low pH con-
formation when it is expressed in the absence of the larger
chain. Although the low pH structure is often thought of as
the ground state, further conformational changes are impli-
cated during fusion of the viral and host membranes. The
protein appears to transit through a series of metastable states
before reaching the ground state. Another way to view this is
that the forbidden disulfide forms a lock on regions of protein
structure of higher potential energy. Reduction of the for-
bidden disulfide releases this stored energy, which is used for
conformational changes that trigger the action of the protein.
Again this notion seems to contravene the thermodynamic
hypothesis of Anfinsen (5) that proteins spontaneously adopt
a minimally frustrated fold. Anfinsen’s discussion of insulin
demonstrates he realized the importance of cleavage of the
protein chain to irreversibility in folding.
Analysis done on disulfide formation during folding of HA
is also illuminating. Disulfides are formed in HA in the ER
during the folding and assembly process. InHA, six disulfides
are formed: four between Cys that are nearest neighbors in
the sequence; and the other two between Cys that are distal in
sequence. Both disulfides formed between the distal Cys pairs
are forbidden. N-glycosylation plays a role in selecting these
two particular disulfide bonds for special treatment (54). A
glycosylation site proximal in sequence to the N-terminal Cys
of each thiol pair recruits calnexin or calreticulin, and the
disulfide linkage is formed by the PDI-like protein ERp57.
Calnexin is specifically involved in the formation of the aCSD
between Cys A4 and CysA466 (B137 after HA cleavage),
whereas calreticulin targets the pCSD formed between Cys
A47 and Cys A274. It is not clear whether ERp57-calnexin=
calreticulin system targets these two disulfides because they
are forbidden, or merely because they are the only two non-
local disulfide linkages in the chain. Several other substrates
of the ERp57=calnexin=calreticulin system contain forbidden
disulfides, but the association has not been investigated at the
level of specific disulfides. These include HIV gp120, Semliki
forest virus E1, integrins, and possibly RNase B. For all
these proteins, glycans influence choice of disulfide partners
and the disulfide isomerase ERp57 is recruited by calnexin=
calreticulin (54).
E. Occult sites
Solvent accessibility is required to enable access by the re-
ductant whether it is ROS, glutathione, or an exogenous
protein molecule. In some cases such as the engineered redox
sensitive GFP, the disulfide always remains solvent accessible
and such cases are straightforward to study. However, in
other cases the disulfide may be protected from solvent and a
conformational change is required to expose the disulfide for
reduction. Examples include: the CSD in influenza HA, which
is exposed during a pH-dependent conformational change
(292); the CSD in CD4, which has been proposed to be solvent
exposed by the process of domain swapping; and the CSD in
DsbD, where a cap structure normally protects the disulfide
(79). Systematic approaches for recognizing these occult sites
are necessary.
V. Conformational Changes in Redox Transitions
Distinct, and sometimes spectacular, conformational
changes can be associated with disulfide formation=reduction
during protein function. Study in this area is difficult because
X-ray structure solution only gives a snapshot of a protein
structure. Conformational changes must be inferred from
multiple independently-solved structures in different redox
states. Unfortunately, circumstances have conspired to thwart
the solution of multiple redox states. Granting agencies and
journals discourage crystallographers from solving structures
twice unless there is an overwhelming biological reason to do
so. In addition, crystallographers often remove ‘‘troublesome’’
Cys residues from proteins of interest bymutation to improve
their handling during purification and crystallization. The
wayward behavior of these Cys residues is likely to be linked
to their redox-activity. Nonetheless, some themes have begun
to emerge from individual studies, but more work is required
in this area.
A. Redox-associated morphing transitions
For some proteins, disulfide formation and reduction is
associated with large-scale plastic deformations of the poly-
peptide backbone (63). These transitions, which have been
referred to as morphing transitions, typically involve un-
ravelling of portions of secondary structure (200). The well-
known redox-sensitive protein OxyR belongs to this group.
In OxyR, a protein of 305 residues, significant refolding of
residues 196–221 occurs between redox states (44). In the
reduced structure, residues 200–204 form a short 310 helix
flanked by regions of coil (Fig. 12). Upon oxidation, residues
196–221 adopt a different fold, with residues 189–193 and
213–218 forming two parallel b-strands joined by a loop with
a disulfide linkage between Cys 199 and Cys 208. In the
reduced OxyR structure, the two Cys that form the disulfide
are separated by almost 13A˚. Cys 199 in OxyR is known to
undergo alternate modifications such as oxidation, nitrosa-
tion, and glutathionylation. Because of the spectacular nature
of the transition between the reduced and oxidized struc-
tures, and the existence of alternate modes of redox regula-
tion, the physiological relevance of the disulfide-linked
structure has been called into question (136). From a theo-
retical standpoint, it seems unlikely that a nonphysiological
state could be uniformly adopted by every monomer in the
crystal as required for the structure-solution process. None-
theless, it is easy to understand why people are uncomfort-
able with this notion as this also challenges cherished notions
of a one-to-one mapping of protein sequence to fold put
forward by Anfinsen.
Another protein with an even more spectacular redox-
associated conformational change is the chloride channel
CLIC1: a protein that forms ion channels by inserting itself
into membranes in response to oxidation (168). CLIC1 is ho-
mologous to soluble proteins of the glutathione-S-transferase
superfamily. Unlike conventional membrane-resident ion
channels, CLIC1 is synthesized without a leader sequence,
and appears to reversibly insert itself into cell membranes.
The latent form is the soluble reduced formwhich is present in
the cytosol. Upon oxidation, a strand peels from a three-
stranded b-sheet and adopts a helical conformation, destabi-
lizing the remaining b-hairpin and forming a disulfide
between Cys 24 and Cys 59. The sulfur atoms of these two
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residues are 13.5 A˚ apart in the reduced state. Reorganization
of the CLIC1 subdomain promotes its incorporation into
membranes. Like OxyR, the physiological relevance of the
CLIC1 conformational change associated with disulfide for-
mation is controversial.
Finally, as previously discussed, the detoxification enzyme
arsenate reductase undergoes smaller multiple plastic con-
formational changes associated with a disulfide relay as part
of its reaction cycle (95, 186) (see Fig. 10). The Cys residues of
the second disulfide intermediate (Cys 82–Cys 89) are 10.7 A˚
apart in the reduced structure.
Large physical separation of the reduced Cys pair seems to
be a common feature of many of the reduced states of
morphing proteins and does not preclude disulfide formation.
Possibly attack by a helpermolecule, such as glutathione, may
be required as an intermediate in disulfide formation to
bridge the intervening distance. In the case of OxyR, gluta-
thione is involved in returning the protein to its original state.
Large physical separation of partner Cys residues may rep-
resent an example of negative design against inadvertent
disulfide formation under mild oxidizing conditions.
B. Redox regulation of the quaternary state
Redox regulation of the quaternary state has previously
been associated with cooperative behavior in proteins. Oli-
gomerization may mediate binding with large repetitive
molecules like DNA, or may switch recognition of an en-
dogenous ligand on or off.
The previously discussed conformational change in the
OxyR monomer modulates its quaternary structure state.
OxyR binds to RNA polymerase when oxidized, inducing
gene transcription. Oxidized active OxyR has the same DNA
binding affinity as reduced inactive OxyR. But whereas
reduced OxyR binds only to two adjacent major DNA
grooves, oxidized OxyR binds to four grooves and also binds
RNA polymerase (149, 276). A similar mechanism is utilized
by HoxB5, a protein involved in embryonic development.
HoxB5 binds DNA in vitro when either oxidized or reduced,
but formation of an intramolecular disulfide between HoxB5
monomers is necessary for cooperative binding (74).
An example of a different type of redox-regulated quater-
nary structure change is cytoglobin, a member of the verte-
brate hemoglobin family. Cytoglobin, which resides in the
nucleus and cytosol, is upregulated under conditions of
hypoxia and certain types of stress. Although cytoglobin is a
dimer in both the oxidized and reduced structures, the dimer
interface changes between redox states. Modulation of the
quaternary structure by intermolecular disulfide bonds may
regulate the ligand-binding properties of cytoglobin (248).
The homologous lamphrey hemoglobin is in an equilibrium
state between a low O2 affinity oligomer and a high-affinity
monomer which contributes to its cooperativity. Cytoglobin
has recently been implicated as a tumor suppressor (241).
C. Redox switches, domain swapping,
and amyloid formation
Redox processes may be involved in large conformational
changes in proteins associated with protein aggregation dis-
eases. Several common complex diseases such as Alzheimer’s
disease and type II diabetes are associated with deposition of
amyloid fibrils but have not been proven to be caused by such
deposits (215). Both of these diseases are associated with ox-
idative stress. In addition, familial forms of amyloidosis are
associated with mutations in genes whose protein products
form amyloid. Around 17 or 18 different proteins have been
identified as being amyloidogenic (255) and redox-active
disulfides are found in many of these.
Amyloid diseases are characterized by deposition of pro-
tein fibrils. Amyloid formation results from a conformation
change in a normal protein because of mutation, aging, a
change in the environment, or proteolysis. Although amyloid
is formed by proteins of different folds, the proteins are
believed to adopt a common cross-beta ultrastructure dem-
onstrated by the ability to bind the histological dye Congo
FIG. 12. Morphing transitions in (A)
CLIC1 and (B) OxyR. In CLIC1, a spectacular
reorganization of an entire subdomain of the
protein occurs in response to different redox
conditions. The protein forms atypical ion
channels by inserting itself into membranes in
response to oxidation (left). The soluble re-
duced form resides in the cytosol (right). In
OxyR, a protein of 305 residues, significant
refolding of the C-terminal subdomain occurs
upon oxidation (left). In the reduced OxyR
structure (right), the two disulfide-forming
Cys are separated by almost 13 A˚. (For
interpretation of the references to color in
this figure legend, the reader is referred to
the web version of this article at www.
liebertonline.com=ars).
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Red (24). Redox processes have been implicated in formation
of amyloid. Reduction of disulfide bonds in the amyloido-
genic Bence–Jones protein, a-lactalbumin, and lysozyme leads
to formation of amyloid-like fibrils in vitro (138, 253). A post-
translational cysteinyl modification has also identified in an
amyloidogenic kappa 1 light chain protein (165).
Previous work noted a correlation between proteins that
undergo domain swapping and amyloid (234). In domain
swapping, two or more identical proteins exchange homolo-
gous parts of their structure to generate an oligomeric unit.
Domain swapping may facilitate a number of biological
functions. First, it allows proteins, which tend to be globular,
to cooperatively bind large repetitive biological structures
such as DNA and oligosaccharides. The intertwining of the
polypeptide chains during polymerization probably serves to
improve the structural integrity of the polymerized unit. This
was recently established for human and chicken cystatins and
appears to be a feature of the cystatin superfamily. Domain
swapping may also regulate protein–protein recognition.
Cystatin inhibits two families of cysteine proteases as a
monomer. Upon formation of domain-swapped dimers, cy-
statin loses its inhibitory effect on C1 cysteine proteases be-
cause the inhibitory L1 loop is co-opted by the cross-over
b-ribbon (1). The domain-swapped dimers are still inhibitory
towards C13 cysteine proteases. Thus, the specificity of the
inhibitor is modulated by the domain swapping process. Li-
gand binding can also mediate domain swapping. Diphtheria
toxin domain swaps upon binding to its receptor (169).
Forbidden disulfides are common in proteins that domain
swap, such as diphtheria toxin and cystatin, and proteins that
form amyloid, including cystatin, gelsolin, the amyloid pre-
cursor protein, and serum amyloid component P (Table 2).
Thus there seems to be an anecdotal three-way relationship
between redox-active disulfides, proteins that form amyloid,
and proteins that domain swap (Fig. 13). Not all proteins that
undergo domain swapping contain forbidden disulfides but
an appreciable number of them do, suggesting that redox
switching of protein conformation may be one of several
mechanisms used as regulators of domain swapping. Single
reactive Cys residues may also be involved in redox regula-
tion. Glutathione binding to Cys 60 regulates domain swap-
ping in glyoxalase I (231).
An example of a domain-swapping protein that contains a
forbidden disulfide and also forms amyloid is cystatin C, an
endogenous cysteine protease inhibitor. Cystatin C is accu-
mulated within amyloid-beta (Abeta) amyloid deposits in
Alzheimer’s disease brain as well as the hereditary disease
Icelandic hereditary cerebral amyloid angiopathy; and is
proposed to play a role in Alzheimer’s disease pathogenesis.
In both cystatin and another domain-swapping protein, the
neurotrophin receptor TrK, the forbidden disulfide is on
strands immediately adjacent to a b-strand that constitutes
part of the swapped subdomain. Formation of the swapped
dimer requires temporary disruption of the hydrogen bonds
between one of the forbidden disulfide strands and the adja-
cent swapped strand. Redox regulation of the forbidden dis-
ulfide may be involved in the forward or reverse process.
Biochemical evidence supporting this notion is available for
cystatin. In vitro, the metastable monomer transits to the di-
mer with the help of pre-denaturing elevated temperatures or
levels of denaturant. In vivo, reduction of the CSD has been
implicated in the dimerization process. Formation of domain-
Table 2. Proteins with Redox-Active Disulfides Associated with Domain Swapping and=or Amyloid
Protein Disulfide type Disulfide Domain swaps? Ref. Amyloid? Ref.
diphtheria toxin CSD 461–471 yes 17 no –
cystatin C CSD 97–117 yes 124 yes 161
gelsolin CSD 188–201 no – yes 183
cyanovirin-N 2xCSD 8–22, 58–73 yes 298 no –
serum amyloid P CSD 36–95 no – yes 100
APP CSD 98–105 no – yes 128
KH97 3xCSDs 11–21, 51–72,
271–288
yes 38 no –
NC1-collagen IV 2xCSD 65–71, 176–182 yes 251 no –
TrK BDD 300–345 yes 268 no –
PrP u 179–214* yes 157 yes 185
Mup u 68–161* yes 25 no –
IL5 u A44–B86 yes 188 no –
SOD u 57–146 no – yes 73
APP, amyloid precursor protein; IL5, interleukin 5; KH97, the common beta subunit of granulocyte macrophage-colony stimulating factor,
interleukin-3 and interleukin-5; Mup, major urinary protein; PrP, prion protein; SOD, superoxide dismutase; TrK, neurotrophin receptor; u,
unclassified.
*Domain-swapped dimer involves interchain disulfide.
Redox-active
disulfides
Amyloid DomainSwapping
FIG. 13. Relationship between redox-active disulfides,
proteins that form amyloid, and proteins that domain
swap.
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swapped dimers in TrK occurs spontaneously on binding of
its ligand. The BDD disulfide in TrK becomes more solvent
exposed in the domain-swapped dimer, possibly allowing
PDI or Trx to return it to its monomeric form (Fig. 14).
In Finnish hereditary amyloidosis, the extracellular form of
the actin-interacting protein gelsolin forms deposits. The
structure of gelsolin consists of six homologous repeats of the
same fold but only the second domain forms amyloid (37),
and it is this domain that harbours the CSD between Cys 188
and Cys 201. The CSD is conserved in mammals such as
mouse, human, and pig, but is not found in lobster,Drosophila,
or frog (281). It is close to a high affinity calcium binding site
and calcium is required for oxidation of the disulfide to occur
(281). The protein exhibits different susceptibility to proteases
with and without the disulfide linkage (281). For proteins that
form amyloid generally, redox-activity of the disulfide may
expose a cryptic protease cleavage site which contributes to
amyloid formation.
Redox processes have been implicated in conformational
changes in the amyloidogenic prion protein (PrP). Re-
combinant hamster PrP is converted to a second form, redox
PrP, by a redox process in vitro and this redox PrP form seeds
the conversion of other PrP molecules to the redox PrP form
(157). The converted form shows properties of oligomeriza-
tion and seeded conversion that are characteristic of the
scrapie form of PrP, the form of the protein found in amyloid
deposits. Oligomerization can be reversed in vitro. X-ray fiber
diffraction suggests an amyloid-like structure for oligomer-
ized PrP. In crystal structures of domain-swapped dimers of
PrP and major urinary protein, the disulfide straddles the
hinge loop, the linker that joins the two swapping subdo-
mains. Disulfide isomerization during the domain-swapping
process is required to switch between the intrachain disulfide
bond in the closed monomer and the interchain disulfide
bond in the domain-swapped dimer.
In complex diseases, increased oxidative or reductive stress
may overwhelm the redox homeostasis system and affect the
ratio of domain-swapped dimers to monomers. In genetic
disease, mutations in the vicinity of a critical disulfide may
adversely change its redox potential, and if it is involved in
domain swapping, impact the domain-swapped population.
This seems to be the case for superoxide dismutase (SOD1)
mutants associated with familial lateral sclerosis (FALs), an
age-dependent degenerative disorder of motor neurons in the
spinal cord, brain stem, and brain. SOD1 is largely localized to
the cytosol but is also found in the intermembrane space of
mitochondria. SOD1 is activated by formation of the disulfide
and insertion of Cu by the copper carrier CCS. The conserved
disulfide in SOD1 is essential for activity and unusual because
it remains oxidized in the cytosol. Although the disulfide is
intrachain, it is thought to play a critical role in stabilizing the
SOD1 homodimer. Formation of the disulfide is part of the
SOD1maturation process which is regulated by physiological
oxidative stress. 14 FALs mutants have the common property
of being more susceptible to disulfide reduction than wild-
type protein (261). Toxicity associated with disulfide-linked
multimerization of SOD1 mutants has recently been impli-
cated in the disease mechanism (73).
Not all proteins that undergo domain swapping contain
redox-active disulfides. For example, barnase, calbindin, and
cyclin-dependent kinase domain swap, but do not contain
Cys residues. However, an appreciable number of domain-
swapping proteins do contain redox-active disulfides, sug-
gesting that redox switching of protein conformation may be
one of several mechanisms used as regulators of domain
swapping.
FIG. 14. Domain swapping
in (A) diphtheria toxin and
(B) cystatin C. The closed
monomer is shown in green
on the left. Individual chains
of the domain-swapped dimer
are shown in pink and blue
on the right. The CSD in each
structure is shown in ball
and stick representation. In
diphtheria toxin the entire
C-terminal domain is swap-
ped. The CSD is located in the
C-terminal domain between
Cys 461 and Cys 471 (left:
PDB: 1mdt, right: PDB: 1ddt).
In cystatin C, the disulfide
between Cys 97 and Cys 117
is located on the convex side
of sheet, aligned with the
a-helix on the opposite face of
the sheet (left: PDB: 1cew,
right: PDB: 1tij). (For inter-
pretation of the references to
color in this figure legend, the
reader is referred to the web
version of this article at www.
liebertonline.com=ars).
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VI. Systems Biology Approaches
A. Phosphorylation, calcium, and peroxide
It has become evident that reduction and oxidation of di-
sulfides is another post-translational modification akin to
phosphorylation. Indeed, the two paths are linked. ROS in-
hibits a superfamily of protein tyrosine phosphatases (262,
263). Reversible oxidation of the catalytic Cys residue likely
extends the timeframe of the kinase signaling response by
delaying removal of the phosphate group (222). Thus, multi-
ple signals are integrated by these phosphatases. In classical
Tyr-specific phosphatases, ROS modification converts the
catalytic Cys to a cyclic sulfenamide by reactionwith themain
chain nitrogen of the adjacent Ser residue: inhibiting the en-
zyme, preventing its further oxidation, and likely facilitating
its conversion back to the active form (232, 271). Dual speci-
ficity phosphatases dephosphorylate Thr and Ser residues in
addition to Tyr, as well as inositol phospholipids. Oxidation
inactivates dual-specificity phosphatases by formation of a
disulfide between the catalytic Cys and another nearby Cys.
Examples include PTEN (156), Cdc25 (33), and PRL-1 (250)
(Fig. 15). In all of these phosphatases, a forbidden disulfide is
formed, but the type is not conserved across the entire family.
The disulfide formed in Cdc25 is a forbidden disulfide of the
pCSD variety (33, 293). The forbidden disulfide in PRL-1 and
PTEN is a novel type of BSD known as an End-Twist
(N. Haworth, unpublished data). A similar disulfide forms in
Staphylococcus aureus ArsC as part of the reaction cycle.
Ca2þ handling pathways are also linked to disulfide redox
status (99, 105). For example, stimulation of the B cell antigen
receptor induces oligomerization, phosphorylation, and acti-
vation of downstream signaling components such as phos-
pholipase Cg, which in turn generates inositol triphosphate
(IP3) andmobilizes Ca
2þ (243). The ryanodine receptor, a Ca2þ
release channel located on the sarcoplasmic reticulum–ER, is
also a redox sensor (249, 297, 302). The oxidized channel
correlates with the open state, whereas the reduced form
correlates with channel closure. The IP3 Receptor (IP3R) may
also sense the redox potential because it contains Cys in the
ER lumenal facing loop that lines the channel pore. Conse-
quently, modulation of the redox potential of reactive thiols in
the ER might be a general mechanism by which SERCA 2b,
IP3R, and the ryanodine receptor control ER Ca
2þ.
Homeostasis of some physiologically important metals is
also regulated by disulfides. The PDI homolog ERp57 has
been proposed to modulate Ca2þ release and uptake in co-
ordinate and opposite directions. In particular, oxidization
appears to favor Ca2þ release by opening Ca2þ channels and
inhibiting Ca2þ pumping. On the other hand, reduction seems
to favor Ca2þ uptake by channel closure and increasing Ca2þ
pumping. The combined effect of these two actions helps to
minimize the loss of ER Ca2þ and maximize refilling of Ca2þ
stores, thereby protecting physiological functions of the ER
such as glycoprotein folding. Finally, Zn2þ homeostasis is also
linked to disulfide redox status. This will be discussed in
Section VI-B.
The redox state outside the cell is linked to the redox state in
the cell by signaling pathways. Redox regulation of disulfides
on the extracellular surface of membrane-resident proteins
such as receptors and ion channels may mediate signal
transduction from the outside to the inside of the cell. For
example, forbidden disulfides are abundant in cytokine re-
ceptors (293). An example of this is cell surface Tissue Factor
that can switch the protein’s function between coagulation
and cell signaling (2). Intracellular H2O2 is transiently gener-
ated upon activation of receptors for peptide growth factors
and cytokines aswell as integrin-mediated cell adhesion (222).
In addition, ROS generated outside the cell can also directly
affect intracellular responses. Phagocytic cells, such as mac-
rophages, contain aNADPH oxidase complex that produces a
burst of ROS as part of the innate immune response to infec-
tion. Peroxide-producingNADPHoxidases also produce ROS
in other cells at lower levels (153). Peroxide can freely diffuse
through cellular membranes, but it was recently discovered
that extracellular H2O2 is actively transported into the cell by
some types of aquaporin, a type of membrane-resident
channel (22).
B. The role of Zn2þ in thiol-based redox activity
1. Zn2þ sites in proteins. Unlike transition metals such as
copper and iron, Zn2þ does not participate directly in redox
FIG. 15. Forbidden disulfide
motifs in phosphatases. Phospha-
tases inhibited by formation of a
forbidden disulfide (A) pCSD
formed in Cdc25 (PDB: 1cwr). (B)
The forbidden disulfide motif in
PRL-1 (blue) and PTEN ( pink) is a
novel type of BSD known as an
End-Twist (PDB: 1x24). The di-
sulfide is reduced in the PTEN
structure (PDB: 1d5r). The catalytic
thiol in all structures is indicated in
red. (For interpretation of the ref-
erences to color in this figure leg-
end, the reader is referred to the
web version of this article at www.
liebertonline.com=ars).
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reactions (i.e., it is not involved in reactions that alter its va-
lence). However, it is involved in redox regulation via Cys
ligands in proteins (178). Zn2þ binding changes the properties
of the thiol group, lowering its pKa (178). Just as there seems
to be a bipartite distribution of redox-active and structural
disulfides in proteins (300), Zn2þ sites can also be either redox-
active or structural (178).
Protein X-ray crystallographers typically differentiate two
types of Zn2þ sites: catalytic Zn2þ sites, which in their simplest
mononuclear form have three amino acid sidechains and one
water molecule as ligands; and structural Zn2þ sites, which
have four amino acid ligands (270). From a redox point of
view, a second variable, lability, is important. Some Zn2þ sites
expel Zn2þ upon variation of physiological redox conditions,
whereas others bind Zn2þ tightly, and would not be expected
to release Zn2þ under physiological conditions. We refer to
Zn2þ sites in this first redox-regulated structural group as
‘‘labile’’ Zn2þ sites, and those in the second, purely structural
group, as ‘‘inert’’ (Fig. 16).
Zn2þ ligand identity is a key indictor of Zn2þ site function.
For redox-inert catalytic Zn2þ sites, residues with carboxyl-
ates (Asp, Glu) predominate in binuclear Zn2þ sites, whereas
His is more common in mononuclear catalytic sites (269,
291). In labile catalytic sites, Cys residues predominate as li-
gands. Redox-active catalytic Zn2þ sites have previously been
characterized in betaine-homocysteine S-methyltransferase
(BHMT) and formaldehyde-activating enzyme. These cata-
lytic Zn2þ sites are highly unusual because of their utilization
of Cys residues as ligands instead of the more usual His, Glu,
or Asp. BHMT and MetH are enzymes of sulfur metabolism,
which are redox-regulated in plants (32). In labile structural
Zn2þ sites, Cys residues predominate, sometimes in combi-
nation with His. In sites with four Cys ligands, Zn2þ is bound
by four sulfur (S) ligands, each donated by a Cys residue (S4
site). S4 sites are the most reactive type of structural Zn
2þ site
and are almost as reactive as a free thiol (184). Substitution of
a single His residue for Cys in a redox-active Zn2þ site lowers
the reactivity of the site. His sidechains ligate Zn2þ via the
nitrogen (N). Hence, the order of reactivity of labile structural
sites is largely determined by the Zn2þ ligands with S4> S3N
>S2N2. However, other factors modify the redox potential of
Zn2þ sites including the electronic environment and entropic
factors.
2. Proteins harboring Zn2þ sites and their conformational
changes. Previously described proteins with redox-active
structural Zn2þ sites include transcriptional regulators such as
SMAD, anti-TRAP, and SIRT2; and the molecular chaperone
Hsp33 (117). These proteins reversibly expel Zn2þ to form
disulfides under conditions of oxidative stress. However,
Zn2þ regulation is not confined to the oxidative stress re-
sponse. It is also important for other cellular functions such
as intracellular transport. In small Tim proteins, Cys resi-
dues required for disulfide formation are kept in a transport-
competent and functionally inactive state by Zn2þ ligation
until delivered to the mitochondrion where disulfides form in
FIG. 16. Types of Zn2þ sites in proteins. (A)
Redox-inert structural Zn2þ site in SpeA1 con-
tributes to the thermostability of the protein and
is proposed tomediate recognition ofMHC class
II molecules (PDB: 1uup). (B) Redox-inert cata-
lytic Zn2þ site in carboxypeptidase A (PDB:
4cpa); (C) Likely structural redox-active site in
Nedd8 (PDB: 1tt5); (D) Redox-active catalytic
site in BHMT, an enzyme of sulfur metabolism
(PDB: 1lt8). Zn2þ sites in matrix metallopro-
teases are an ingenious hybrid of structural=
catalytic, redox-active=inert Zn2þ sites. (E) In the
zymogen form of the enzyme, a structural Zn2þ
site is formed by inclusion of a fourth Zn2þ
amino acid ligand: a Cys residue resident on a
propeptide (PDB: 1l6j). In a redox-controlled
activation step, the Cys detaches to activate the
enzyme (83, 267). (F) the redox-inert catalytically
active form (PDB: 2ovx) (245).
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the intermembrane space in more oxidizing conditions com-
pared to the cytosol (170).
Structural changes that occur upon Zn2þ loss and subse-
quent oxidation of these proteins are varied. In enzymes, such
as BHMT, very small conformational changes can be sufficient
to have a major effect on activity (58). However, large con-
formational changes also occur. In T. thermophilus Leu-tRNA
synthetase, a large order=disorder transition is associated
with reversible Zn2þ binding. In the pre-transfer complex, a
disordered region of polypeptide chain is partially stabilized
by a disulfide formed between Cys 439 and Cys 484 (167). In
the more ordered post-transfer complex, the polypeptide
chain forms a small b-sheet that tetrahedrally coordinates a
Zn2þ atom (266). The Zn2þ site is conserved in eukaryotic
mitochondrial Leu-tRNA synthetases but not in the cytosolic
form of the enzyme. When four Cys residues are bound to
Zn2þ, the conformational space of the resident polypeptide
chain is more constrained than if the Cys residues form one, or
even two, disulfide bonds. Expulsion of Zn2þ and subsequent
oxidation increases the entropy of the chain. Reversible Zn2þ
binding is also associated with changes in quaternary struc-
ture. Most commonly, Zn2þ binding can induce oligomeri-
zation. An example occurs in iNOSwhere a redox-active ZnS4
site is formed at the dimer interface. Oxidation of the Cys
ligands results in dissociation of the dimer to two monomers,
uncoupling nitric oxide synthesis (307). However, the oppo-
site behavior is also known: the Zn finger motif in the
monomer of cellulose synthase (CesA) is proposed to partic-
ipate in oxidative dimerization of the enzyme. Zn2þmaintains
the protein in its monomeric state and a covalent dimer is
formed upon oxidation (150).
Upon Zn2þ expulsion from a redox-active site, disulfides
do not form randomly between free thiols. In an S4 site, six
different disulfides are possible but one of these tends to be
selected. This preferred disulfide is known as the trigger
disulfide (304). Some known variables that influence selection
of a preferred disulfide are the presence of His residues in the
site (deselection), and electrostatic effects of nearby residues.
Our work suggests the structural context of Cys Zn2þ li-
gands may also be important in function. Two forbidden
disulfides motifs, the JSD and BDD, are associated with likely
redox-active Zn-binding sites in proteins (64). An example of a
Zn2þ-associated JSD is found in nicotinate phosphoribosyl-
transferase (NAPRTase) from Thermoplasma acidophilum, an
archaeal thermophile. NAPRTase catalyzes the first, rate-
limiting reaction in NAD salvage synthesis. The C-terminal
Zn knuckle domain contains the JSD (239). This domain is
unique to T. acidophilum and is not found in other NAPRTases,
but has structure and sequence similarities to other Zn
knuckle domains such as one found in the DNA replication
initiator from Methanobacterium thermoautotrophicum, which
mediates intersubunit interactions (66). In both cases, Zn2þ is
bound by a CXXC(14–24)XCXC motif. In NAPRTase, the JSD
forms between the first and third Cys of the motif. Another
example is in the previously mentioned bacterial Leu-tRNA
synthetase that is conserved with the mitochondrial homolog
in eukaryotes. The post-transfer complex (266) contains a re-
duced JSD motif that binds Zn2þ in a CXXC41XCXXC motif.
In the pre-transfer complex, the b-sheet is disrupted and a
disulfide formed between the first and third Cys of the motif
(167). These two examples and others shown in Table 3,
suggest there may be a relationship between the JSD motif
and reversible Zn2þ binding. Another characterized JSD-
containing protein is defensin. While there is no direct evi-
dence that defensins bind Zn2þ, they mediate Zn2þ tolerance
in plants (190). Human defensins contain two potential Zn2þ
binding sites.
The other forbidden disulfide motif commonly associated
with Zn2þ binding is the antiparallel BDD. In most instances,
the two Cys residues are in the hydrogen-bonded site (h) of
adjacent strands (aBDDh) on a b-hairpin (290). Most examples
are embedded in a CXXC sequence motif but C3XC and CXC
sequence motifs are also represented. The shaded examples in
Table 3 are structures that contain both a JSD and an aBDDh
within a single Zn2þ site. The significance of these composite
motifs is unclear. Differential modification of composite sites
may modulate different responses to ROS=RNS, or alterna-
tively, disulfide isomerization may occur during the Zn2þ
redox cycle.
The co-occurrence of forbidden disulfide motifs of the
aBDDh type with labile Zn2þ binding sites is particularly
interesting because of the recent characterization of the oxi-
dative process leading to activation of the bacterial chaper-
one Hsp33 (117). In Hsp33, oxidative modifications of the
N-terminal Cys residues of the Zn2þ site in the linker region
are proposed to release Zn2þ from the structure. The aBDDh
disulfide is formed between the two unmodified C-terminal
Cys of the Zn2þ site (117). The function of disulfide formation
between Cys 269 and Cys 272 in the Zn2þ binding site has not
been fully delineated. Potential benefits are protection from
other oxidative modifications and restriction of the confor-
mational freedom of the protein chain, allowing easier
refolding upon return of the protein’s milieu to normal con-
ditions. However, these benefits apply to any disulfide and
the repeated appearance of the aBDDh in labile Zn2þ sites
suggests a more specific function, possibly recognition by a
foldase or metallochaperone. We hypothesize the forbid-
den disulfide would become stressed upon condensation of
the b-sheet in its vicinity (293), possibly allowing easier
re-insertion of Zn2þ (Fig. 17).
A common fold associated with reversible Zn2þ binding is
the nucleic acid-binding Zn finger. Whereas other DNA-
binding proteins generally make use of the twofold sym-
metry of the double helical structure of DNA for binding, Zn
fingers do not. As such, Zn fingers can be arranged linearly in
tandem to recognize DNA sequences of different lengths
(139). This special property also makes Zn fingers equally
at home binding RNA as well as DNA (139). Many RNA-
interacting proteins contain likely redox-active Zn2þ sites
including amino acid tRNA synthetases, RNA=DNA poly-
merases, ribonucleotide reductase, and the ribosome. Zn fin-
gers have been classified into eight different structural types
(146). The aBDDh motif seems to be a common feature of
many of these structural types. In C2H2-like Zn fingers and
GAG knuckles, the N-terminal pair of Cys ligands can be
found as a reduced aBDDhmotif. In C2H2 Zn fingers, the two
C-terminal Zn2þ ligands are His residues. If the function of
C2H2 Zn fingers is analogous to activation of Hsp33, pH
changes rather than oxidative stress may initiate Zn2þ ex-
pulsion from these folds. A third major structural group is the
treble clef Zn finger which consists of two distinct subgroups:
one of these ligates a single Zn2þ atom; while a second group,
which ligates two Zn2þ atoms, are known as cross-braced Zn
fingers (180). Among treble clef Zn fingers, aBDDh motifs are
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mostly associated with cross-braced treble clefs that bind
phospholipids including FYVE, PhD, and DAG-binding Zn
fingers. aBDDh motifs are generally not found in the other
major group of cross-braced Zn fingers, RING domains, and
are only occasionally found in non-cross-braced treble clefs,
mostly in LIM domains where the N-terminal pair of Cys
ligands of the first of two Zn2þ sites is found in an aBDDh
motif. A fourth structural group are the Zn ribbons. In some
Zn ribbons, such as rubredoxin-like domains, the N-terminal
thiols are often present in a reduced aBDDh motif, while in
others, such as members of the general transcription factor IIB
and IIS families, the C-terminal Zn2þ ligands form a reduced
aBDDh motif. In summary, in *50% of Zn fingers with de-
fined secondary structures, two of the Cys Zn2þ ligands are
present in a reduced aBDDhmotif.While only a handful of Zn
fingers with aBDDh motifs have been crystallized in the oxi-
dized state, the behavior of Hsp33 may represent the general
behavior of the aBDDh motif in Zn fingers: where nonmotif
Zn2þ ligands release Zn2þ, triggering formation of the aBDDh
forbidden disulfide in the oxidized state. Further work needs
to be done to determine whether this is the case.
Zn2þ binding is not associated exclusively with these spe-
cialized domains. Zn2þ sites may alternatively be added to
other existing non-Zn2þ binding proteins both by point mu-
tation such as in BHMT, and by domain insertion such as in
TaNAPRTase.
3. Zn2þ as a second messenger and its physiologic sig-
nificance. Upon release from a protein under oxidative
stress, Zn2þ can act as a second messenger. Extracellular and
intracellular free Zn2þ can have important signaling func-
tions, such as inhibition of gamma-aminobutyric acid (GABA)
FIG. 17. Forbidden disulfide motifs
associated with Zn2þ binding. (A)
Oxidized structure of the Zn2þ knuckle
domain in Thermoplasma acidophilum
NAPRTase. The JSD formed between
the first and third Cys is indicated with
an arrow. A disulfide conforming to an
aBDDh motif can be formed by is-
omerization of the two Cys residues
colored pink. (PDB: 1ytd). (B) Structu-
rally similar site in the DNA replication
initiator fromMethanobacterium thermoautotrophicum with Zn2þ bound (PDB: 1ltl). (For interpretation of the references to color
in this figure legend, the reader is referred to the web version of this article at www.liebertonline.com=ars).
Table 3. Forbidden Disulfide Motifs Associated with Zn2þ Binding
Protein Site Sequence motif Fold FD PDB Ref.
JSDs
TaNAPRTase S4 CXXC14XCXC Zn knuckle 330–348 1ytd 239
TtLeu-tRNAs S4 CXXC41XCXXC Zn knuckle 439–484* 1h3n 51
TtIle-tRNAs S4 CXXC37XCXC Zn knuckle 461–502* 1ile 202
HsBHMT S3 C81XCC TIM barrel 217–299 1lt7 58
TmMetH S3 C64XCC TIM barrel 207–272 1q7m 59
EcGTPhI S2N CXXH67XC T-fold 110–181 1gtp 10
Nv3c-like protease S3 C5XC70XC Trypsin-like
{ 83–154* 1wqs 201
aBDDh
Hssurvivin S3N CXXC16XH6XC Iap-repeat 57–60 1f3h 274
HsBIRC8 S3N CXXC16XH6XC Iap-repeat 300–303 1xb1 240
EcATCase S4 C3XC23XCXXC rubredoxin-like 138–141 1r0b 110
PafdhE S4 CXXC27XCXXC rubredoxin-like
{ 256–259* 2fiy –
TmSir2 S4 CXXC20XCXXC rubredoxin-like 124–127* 2h59 103
HsSir2 S4 C3XC20XCXXC rubredoxin-like 195–200* 1j8f 65
DrRecR S4 CXXC8XCXXC Zn finger 57–60* 1vdd 154
TtVal-tRNAs S4 CXXC14XCXXC Zn knuckle 417–420* 1gax 72
TtIle-tRNAs S4 CXXC37XCXC Zn knuckle 502–504 1ile 202
TtLeu-tRNAs S4 CXXC41XCXXC Zn knuckle 484–487* 1h3n 51
TaNAPRTase S4 CXXC14XCXC Zn knuckle 330–333* 1ytd 239
BsHsp33 S4 CXC30XCXXC Hsp33 redox switch 268–271* 1vzy 122
MtMsrB S4 CXXC30XCXXC Mss4-like 67–70* 2k8d –
HsRabGEF S4 CXXC67XCXXC Mss4-like 23–26* 2fu5 119
Shaded rows contain composite sites. Site column-catalytic sites are in italics; sequence motif column-Zn2þ ligands are bold, forbidden
disulfide (FD) motif Cys are underlined; Fold classifications are from SCOP (199), FD column: *motif present is reduced or isomerized; bound
atom in crystal structure is {Fe, {Hg. Additional protein abbreviations: ATCase-asparate transcarbamylase, BHMT, Birc8, fdhE, GTPhI-GTP
cyclohydrolase I, Hsp33-heat shock protein 33, MetH, MsrB-methionine sulfoxide reductase B, NAPRTase, RabGEF-Rab guanine nucleotide
exchange factor, RecR, Sir2-SIR2-like NAD-dependent histone deacetylase, tRNAs – tRNA synthetase, iap-inhibitor of apoptosis. Other
protein names are standard. Species: Bs, Bacillus subtilis; Dr, Deinococcus radiodurans; Ec, Escherichia coli; Hs, Homo sapiens; Mt,
Methanobacterium thermoautotrophicum; Nv, Norovirus; Pa, Pseudomonas aeruginosa; Ta, Thermoplasma acidophilum; Tm, Thermotoga maritime;
Tt, Thermus thermophilus.
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ergic neurotransmission (107) or modulation of protein kinase
C signaling pathways (143).
Zn2þ is buffered in the cell by the metallothionein=thionein
pair (35, 176, 207). Thioneins are small proteins, typically
*6–7 kDa, with a high proportion of Cys residues which can
coordinate multiple Zn2þ atoms. In the most common types,
up to seven Zn2þ atoms can be bound by 20 Cys residues
(173). Zn2þ binds with high affinity to the Cys within me-
tallothionein lowering intracellular free Zn2þ to the pico- to
nanomolar range. Oxidation or nitrosation of metallothionein
Cys residues can release Zn2þ (174, 175, 203) that can subse-
quently bind to other proteins. Physiologic changes of the
glutathione redox potential affect the redox state of me-
tallothionein and the amount of free Zn2þ available for
binding by proteins. The redox potential of metallothionein
is less than 366mV. Recently, thionein was identified as a
reducing agent for methionine sulfoxide reductase (230).
Low intracellular free Zn2þ concentrations are maintained
under normal homeostatic conditions. Under basal physio-
logical conditions, Zn2þ buffering systems keep the concen-
tration of free Zn2þ in the subnanomolar range (48, 178). Like
ROS, the amount of free Zn2þ correlates with different cell
states. The amount of free Zn2þ is 614 pM in resting cells,
1.25 nM in undifferentiated cells and >2.5 nM in apoptotic
cells. Cellular free Zn2þ is also controlled by membrane im-
porters of the Zip family and exporters of the ZnT family (56),
as well as the metal response element transcriptional fac-
tor (270).
Zn signaling seems to have a special role in the brain. In
neurons of the mammalian cerebral cortex, Zn2þ is selectively
stored with the neurotransmitter glutamate in synaptic vesi-
cles, released into the synapse upon excitation, and enters
postsynaptic neurons through Zn2þ-permeable gated chan-
nels (6, 40, 71, 108, 258, 273). Physiologically relevant con-
centrations of Zn2þ alter the activity of GABA and glutamate
(NMDA receptor subtype) gated channels and other synaptic
proteins. Zn2þ is thought to be important in synaptic plasticity
(29, 163), required for memory and learning. The importance
of Zn2þ in brain function is also reflected in the brain’s Zn2þ
content. The amount of Zn2þ in the mammalian brain aver-
ages *10 mg=g (wet weight) (70). Zn2þ concentrations in the
serum and extracellular fluid are estimated to be 0.15 mM
(254). The concentration of Zn2þ inside synaptic vesicles is
micro- to millimolar (69). Thus Zn2þmay play a central role in
the effect of oxidative stress on the brain, of importance to
neurodegenerative diseases such as Alzheimer’s disease.
Zn2þ is also essential to proper development of the nervous
system (217).
In summary, for structural Zn2þ sites an analogous situa-
tion may exist to the bipartite distribution of redox-active and
structural disulfides in proteins, with labile Zn2þ sites being
redox-active and inert Zn2þ sites corresponding to the purely
structural group. Zn2þ can inhibit enzymes such as caspase-3,
fructose 1,6-diphosphatase, glyceraldehyde 3-phosphate de-
hydrogenase, aldehyde dehydrogenase, tyrosine phospha-
tases and yeast enolase. Addition of thionein can restore
activity by acting as a Zn2þ-chelating agent (174). On the other
hand, release of Zn2þ can inactivate other proteins such as
DnaJ which must be reactivated by Trx reduction. The reader
is referred to more extensive reviews on the role of Zn2þ
regulation and its importance for neurochemistry (147, 178,
270).
VII. Global Approaches to Identifying
Redox-Active Cys
A. Proteomic approaches to identification
of redox-active Cys
Developed over the last 10–15 years, experimental ap-
proaches to detection of reactive Cys residues by labeling are
sufficiently refined to be applied at the proteome level. H2O2
and iodoacetamide selectively and competitively react with
Cys of low pKa. In early work in 2000, a decrease in labeling of
cell lysate proteins with a biotin-conjugated iodeacematinide
reagent was observed following exposure of cells to H2O2, or
to an agent that induces H2O2 production (135). Labeling was
monitored by streptavidin blot analysis. Modified proteins
were identified by immunoprecipitation, a technique which
requires preparation of specific antibodies against each pro-
tein of interest. A novel modified peptide within creatine
kinase was detected by trypsin-digestion, followed by sepa-
ration of the fragments by high performance liquid chroma-
tography (HPLC). Further analysis by partial Edman
degradation and mass spectrometry identified the peptide
sequence containing a single modifiable Cys residue. In an
advance that increased the scope for discovery of novel pro-
teins, iodoacetamide reagents of different mass were conju-
gated to reactive thiols in separate reactions. Pooling of the
results, followed by trypsinization and purification by HPLC
potentially allowed novel peptides to be identified in fractions
by mass spectrometry through iodoacetamide-conjugate
doublets (238). Both these techniques, which were performed
on fully folded proteins, are limited by access of the reagent to
the reactive Cys (135), particularly when large reagents such
as biotin are involved.
Differential thiol trapping techniques attempt to solve the
problem of reagent access by denaturing proteins before
conjugation. In differential thiol-trapping, the folded pro-
teome is exposed to oxidative or nitrosative stress, resulting
in a spectrum of modifications to susceptible thiols. The
proteome is then denatured and unmodified thiols are la-
beled irreversibly with an iodacetamide reagent. Reversible
thiol modifications (i.e., disulfides or sulfenic acid, but not
sulfinic and sulfonic acid) are then reversed using a strong
reductant and labeled with a visualizable form of the same
iodacetamide reagent. For example, the second iodacetamide
reagent used to label modifiable thiols may be radioactive
(158) or fluorescent (102). Modified proteins are commonly
visualized using two-dimensional gel electrophoresis. Pro-
teins spots can potentially be excised, digested using trypsin,
and modified peptides identified by mass spectrometry
(158).
A recent improvement on the differential thiol-trapping
technique is the OxICAT method which adds the advantages
of detection by iodoacetamide-conjugate doublets (160). In
OxICAT, unmodified thiols are labeled irreversibly using a
‘‘light’’ 12C-based form of an iodacetamide reagent called
ICAT. Reversible thiol modifications are then reversed using
the strong reductant Tris(2-carboxyethyl)phosphine and la-
beled with the ‘‘heavy’’ 13C-based form of the same ICAT
reagent. After trypsin digestion, peptides with single revers-
ible thiol modifications are 9 Da heavier than their unmodi-
fied form, allowing modifiable proteins to be identified, and
the relative abundances of the modified and unmodified
forms to be quantified using mass spectrometry. Tandem
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mass spectrometry can be used to identify modified peptides
and hence potentially oxidized Cys.
Proteomic approaches are currently limited by the quanti-
ties of proteins that can be obtained. Many proteins identified
to date are components of redox homeostasis systems, or
highly abundant target proteins such as ribosomal proteins in
easily cultivated organisms (160). The resolution of these
systems is constantly improving. Only proteomic approaches
with the potential to identify individual redox-reactive Cys
have been discussed briefly here. For additional methods, the
reader is referred to more detailed recent reviews on the
subject (159, 191).
B. Bioinformatic approaches to prediction
of redox-active Cys
Early studies that attempted genome-wide identification of
redox-regulated proteins using computational approaches
looked for the presence of Zn2þ or selenocysteine in sequ-
ences. Conour et al. (49) used sequence-based Zn2þ signatures
from InterPro (114) to search for redox-regulated proteins in-
volved in regulation of the cell cycle. InterPro is a meta-
database of motif and domain-based sequence signatures
integrated from multiple sources. While several likely redox-
regulated proteins were found, this studywas not exhaustive.
Significantly, many Zn2þ sites are not found by these signa-
tures (177). Furthermore, no attempt was made to distinguish
structurally stable Zn2þ sites from labile Zn2þ sites which
could be involved in redox activity (177, 184). Further studies
are necessary to identify the most reactive thiols in these sites.
Amore recent study by Fomenko et al. (68) used a sequence-
based technique which predicts redox-active Cys based on
homology to selenocysteine (Sec) in other organisms. Sec is an
isostere of Cys where the sulfur is replaced by selenium. Sec
has a significantly lower pKa than Cys and thus is more re-
active in the same context. It is known as the 21st amino acid
acid in ribosome-mediated protein synthesis and its specific
incorporation is directed by the UGA codon. Because UGA is
also used as a stop codon, recognition elements within the
mRNAs, known as SECIS elements, are essential for transla-
tion of UGA as Sec. Unique tRNAs that have complementary
UCA anticodons are aminoacylated with serine. The seryl-
tRNA is converted to selenocysteyl-tRNA that binds specifi-
cally to a special elongation factor and is delivered to the
ribosome.
The study by Fomenko et al. represents the first time in-
herent redox properties of a biological molecule have been
used to identify redox activity in a resident protein, however
the technique has several limitations. One limitation of the
Cys–Sec pair method is that it is restricted to proteins found in
reducing compartments. Work to date on redox regulation in
bacteria and eukaryotes has concentrated on redox regulation
in the cytosol. Only a few cell surface proteins such as CD4,
integrins, and Tissue Factor have been demonstrated to con-
tain redox-active disulfides (2, 104), but it is likely these
studies represent the tip of the iceberg. In addition, only those
Cys that carry out catalytic functions (e.g., attacking nucleo-
philes) are identified by the Cys–Sec pair method, whereas
Cys that serve supporting functions (e.g., resolving Cys) are
not detected (68).
Physicochemical approaches to discriminate between redox-
active and structural disulfides in protein structures have also
been attempted. The calculation of individual redox poten-
tials within protein structures is currently not computation-
ally feasible. Disulfide redox potential is a function of
electrostatic screening, entropic effects, and physical stress
applied to the disulfide bond both through stretching and
twisting. The redox potential contains both pH-dependent
and pH-independent parts (43). Thus pKa,which is often used
to estimate redox potential, is not entirely predictive. Nor is
the calculation of pKa possible in a high-throughput manner.
Estimation of redox activity via some of these variables rep-
resents a more accessible approach.
Whitesides and co-workers used molecular mechanics
calculations to investigate factors that affect the redox po-
tential of two thiols in molecules with similar structure and
thiol pKa (36). The most important parameters were the three
central dihedral angles of the disulfide bond (w2, w3, w20). Ex-
perimental work has confirmed that torsional energy is an
important variable influencing disulfide redox activity (131,
280, 283). The AMBER forcefield (213) was previously used to
estimate disulfide torsional energies in a high-throughput
manner using solved protein structures (292). More recently,
interpolation on a potential energy surface calculated using
more detailed quantum chemical calculations of the model
compound diethyl disulfide has allowed more accurate esti-
mation of disulfide torsional energies in protein structures
(95). Disulfides with very high torsional energies are likely to
be redox-active and may be reduced by purely mechanical
means such as stretching and twisting. For example, a short-
lived disulfide intermediate formed between Cys 10 and Cys
82 as part of a disulfide cascade during the reaction cycle of S.
aureus arsenate reductase is estimated to have a torsional
energy of 24.0 kJmol1 (95).
However, as discussed earlier, these very unstable high
torsional energy disulfides are not the only ones likely to be
redox-active. Most forbidden disulfides have torsional ener-
gies in the intermediate energy range. Forbidden disulfides
account for only *10% of disulfides with torsional energies
>10kJmol1 and constitute an even smaller proportion of
very high energy disulfides. Their metastability is likely an
important feature of their biologic function. While they are
unlikely to undergo spontaneous reduction, they are likely
to be far more susceptible to redox attack than low energy,
structural disulfides. Although forbidden disulfides were
originally identified by physiochemical analysis of stresses in
crystal structures, once canonical motifs have been identified
they can easily be mined from crystal structure coordinates.
Structural data-mining methods based on torsional energy
analysis and forbidden disulfide motif identification only
consider static mechanical energy contributions to increasing
the redox potential. Other variables likely to influence the
redox potential include the electrostatic environment; and
dynamic stress applied to the disulfide through directed
stretching and twisting, as well as by Brownian motion. To
identify disulfides that rely on these other means for reduc-
tion, an alternative method that adopts an entirely empirical
approach has recently been developed. In this technique,
redox-active disulfides are identified empirically by mining
redox pairs of structures from the PDB (64). In protein redox
pairs, Cys are disulfide bonded in one crystal structure but
reduced in another structure of the same, or a highly similar,
protein. Redox-active disulfides are more likely to be in al-
ternate redox states in a crystal structure than structural
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disulfides whose disruption is likely to greatly impair the
protein’s stability. For example, redox-active disulfides are
likely to be selectively reduced by X-ray radiation during
the structure solution process and their oxidation state is more
susceptible to changes in pH. Potential redox-active disulfides
identified by this purely empirical technique include high
torsional energy disulfides and forbidden disulfides. A limi-
tation of the Redox Pair technique is that it requires the pro-
tein structure to be solved independently at least twice under
different redox conditions.
The three structure-based techniques using torsional en-
ergy analysis, recognition of forbidden disulfides motifs, and
detection of Redox Pairs have recently been applied to iden-
tification of proteins harboring redox-active Cys in the yeast
genome (63). The results showed reasonable agreement with
reactive Cys deduced experimentally as well as predicting
many novel proteins. Further experimental investigation of
these results will hopefully allow the accuracy of the methods
to be better delineated.
The structure-basedmethods described are not restricted to
the cytosol and can be used to identify redox-active Cys in
other redox-regulated compartments such as plasma and
mitochondria. For instance, several vacuolar proteins were
implicated in the yeast genome study (63). Because disulfides
are used as the starting point, predictions are not limited to
catalytic Cys. For instance, resolving thiols can be predicted.
Furthermore, the methods are not restricted to redox-active
Cys in catalytic sites and can predict redox-active Cys other
than catalytic disulfides, such as regulatory redox-active Cys.
Structure-based prediction methods can be extended to the
sequence level by homology-based sequence searching.
Theoretical studies to identify redox-regulated Cys (49,
68) are a valuable alternative approach to high throughput
experimental methods which will hopefully help define the
area of thiol-based redox regulation and act as a catalyst for
further experimental studies. Computational methods are
complementary to high-throughput approaches such as mi-
croarrays and two-dimensional gels, which can identify
particular proteins that are under redox control but are un-
able to identify particular thiols through which redox control
is exerted. Specific residues critical to redox activity can be
identified and subsequently tested by mutagenesis. While
not limited by protein abundance like proteomic methods,
computational methods have their own drawbacks. For ex-
ample, while a specific Cys may be identified as redox-
active, the method may not identify under what conditions
it is redox active (i.e., by which assay redox-activity would
be uncovered). Inspection of individual predictions may be
helpful here, as well as considerable experimental insight.
Combining computational predictions with experimental
results would be useful, and can also provide an additional
level of quality control with high throughput approaches
such as yeast deletant screening.
VIII. Evolution of Thiol-Based Redox Regulation
A. Evolution of protein cysteine content
Early studies on protein sequences indicated Cys is more
abundant in more complex organisms (61, 192). This has been
confirmed by more recent studies on whole genomes that
have shown the abundance of Cys in proteins has been
increasing since divergence from the Last Universal Com-
mon Ancestor (27, 288), and this increase is a continuing
pan-species phenomenon which is evident within the last
10 million years (126).
This has important implications for protein structure.
Structural domains in proteins are independent folding units
(282). From a domain viewpoint, Cys is more likely to be
present within similar domains if they are present in more
complex organisms. Given that disulfide-forming Cys can
have either a redox role or a role in structural stabilization,
two hypotheses present themselves: first, that any given do-
main is increasingly unstable in more complex organisms,
and needs additional covalent cross-links; or alternatively,
thiol-based redox signaling is more prevalent in organisms of
increasing complexity.
Although the prevalence of Cys in proteins is increasing,
the abundance has not yet reached the neutral frequency (i.e.,
the frequency that would be expected based on the number of
Cys codons in the genetic code) (27, 137). Based on the absence
of Cys and some other amino acids from the Murchison me-
teorite, and the inability to produce these same amino acids
abiotically in spark experiments (189), it seems likely that Cys
belongs to a group of amino acids that were added late to the
genetic code after development of biotic pathways to enable
their synthesis (289). Being a latecomer, it has been suggested
that insufficient time has passed to allow Cys to reach its
equilibrium frequency (28, 126). However, Phe was also likely
recruited late to the genetic code, and postdates the intro-
duction of Cys (265). In contrast, the abundance of Phe in
complex organisms is higher than would be expected based
on neutral frequencies (27).
Although prebiotic amino acids do seem in general to be
decreasing in abundance while late-coming amino acids are
increasing, other factors may affect the rate of acquisition.
Although there is still some disagreement over which amino
acids are increasing in frequency, it is agreed that Cys and Phe
are increasing (27, 126). One study suggests Tyr might also be
increasing (27), while another suggests Met, His, and Ser are
becoming more abundant (126). These data are based on a
small number of completely sequenced genomes and the
methods examine different epochs in evolutionary time. They
may yet be reconciled by specific trends within subgroups
or epochs. A common property of these increasingly more
prevalent residues is their role in signaling either through
post-translational modifications by ROS (Met, Cys), phos-
phorylation (Ser, Tyr); or other signaling modes such as pH
responsive elements (His, Cys), and p–p signaling (Tyr, Phe).
An alternative explanation for the failure of Cys to reach its
equilibrium frequency is that incorporation of additional Cys
into proteins may come at a cost. In the case of Cys, increased
signaling and control may be gained at the cost of deleterious
effects of over-oxidation. Our preliminary data suggests
redox-active Cys has been increasingly incorporated into ge-
nomes all the way up to mammals, which represent the most
extensive users of thiol-based redox signaling on the planet.
Thus, increased usage of Cys correlates with increased or-
ganismal complexity. Before multiple genome sequences
were complete, it was generally believed increased complex-
ity correlatedwith gene number. The small differences in gene
number between simple unicellular eukaryotes andmammals
forced revision on how complexity is encoded. For example,
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the yeast genome contains 5,000 genes, yet the human genome
contains only five times more: 25,000. Some geneticists now
argue that additional complexity at the organismal level must
be encoded at the molecular level by noncoding DNA, as this
is considerably different between these organisms (182).
While additional control elements in genomes almost cer-
tainly play an important role in encoding additional com-
plexity, the studies on changing amino acid content suggest
increased complexity may also be encoded at the protein
level. It was previously recognized that concatenation of
existing domains through gene fusion, also known as protein
domain mosaicism, encodes new functions in more complex
organisms (210). We will call this the ‘‘Lego’’ hypothesis.
However, studies on the changing amino acid content of
proteins show that domains too are not static structures.
Nature is continually tinkering with these independent fold-
ing units.
This is a somewhat surprising realization. For many years
structural biologists believed the planetary proteome consists
of a limited set of 1,000–5,000 folds that form a universal con-
struction set (45). The ‘‘divide and conquer’’ approach and
automation of structure solution posit that solution of the
universal construction set would give us complete knowledge
of the molecular structure of the planetary proteome. But here
is a caveat: a domain from archaea may not have the same
sophisticated set of switches as the homologous domain from
a mammalian protein.
Additional complexity added to protein domains in the
form of redox and other switches likely increase the signaling
capabilities of individual domains. It also suggests the energy
landscape at the bottom of the folding funnel is likely to be
more complex in a domain from a higher organism than a
homologous domain from a lower organism. Pursuit of a
complete knowledge of fold space is worthy, but it does not
give us a complete knowledge of proteins.
B. Origins of thiol-based redox signaling
The origin of thiol-based redox signaling is very ancient
and rather murky. Evolutionary studies comparing the pro-
tein complement of genomes have determined Trx is found in
every lineage in the Clusters of Orthologous Groups (COGs)
database (256, 257). Thus the Last Universal Common An-
cestor is proposed to contain a Trx. Most other proteins for
which this is true are involved in transcription and transla-
tion.
The earliest evidence of life on earth comes from analysis of
3.5 billion year-old cherts that suggest anaerobic photosyn-
thetic prokaryotes inhabited marine environments around
this time (260). Based on these data, the Last Universal
Common Ancestor is often dated at 3.5 billion years (15).
However, given the increase in the oxygen content of the at-
mosphere only began *2.5 billion years ago (212), before
which the earth is believed to have had a reducing atmo-
sphere, it seems likely that Trx was only incorporated into a
genome after this change in atmospheric content. This sug-
gests that the Last Universal Common Ancestor occurred
<2.5 billion years ago and whatever life existed on the
planet during the first billion years was supplanted by or-
ganisms capable of dealing with the new oxygen-based at-
mosphere.
The enzyme capable of reducing Trx, however, is not uni-
versal. In bacteria and animals, reducing power is provided
by the NADPþ-dependent TrxR. In plants, this enzyme op-
erates in the cytosol but an additional enzyme, FTR is used in
chloroplasts. Plastids themselves are thought to have origi-
nally been free-living organisms that were incorporated into
plants in a symbiotic event. The FTR system was previously
assumed to be present in all oxygenic photosynthetic cells, but
was recently determined to be absent from some cyano-
bacterial species likely to be of very early origin (67). In these
slow-growing species, NADPþ-dependent TrxR meets the
limited needs of these organisms for photosynthesis. Thus,
FTR appears to have been added in plants as an auxiliary
system to deal with high electron fluxes.
Other evidence that redox control was acquired very early
in the evolution of life on Earth come from archaea. Evidence
has emerged of specialized use of Cys within some archaeal
subgroups, particularly in the cytosol. Disulfide bond map-
ping suggests >40% of Cys in cytosolic proteins of crenarch-
aeal genomes participate in disulfide bonds, and >30% in the
Pyrococcus branch of euryarchaea (172), far more than pre-
dicted for cytosolic proteins in bacteria and eukaryotes. The
propensity of these organisms for even numbers of thiols in
the cytosol was also noted. Additional support for enrichment
of cytosolic disulfides was provided by discovery of protein
disulfide isomerase-like enzymes encoded in a subset of ar-
chaeal genomes predicted to have disulfide-enriched cytosols
(152). It was hypothesized that the increased number of in-
tracellular disulfides in these hyperthermophilic subgroups
was a mechanism for achieving thermostability. However not
all hyperthermophiles have disulfide-enriched cytosols (16).
Alternatively, the increased number of disulfides could be
involved in the process of redox regulation. Although redox
regulation was briefly considered as an alternate hypothesis
in the original work, it has not been systematically inves-
tigated. It is interesting to note that of the two disulfide-
enriched subgroups, the crenarchaeal group contains aerobic
organisms (133, 275), whereas hyperthermophiles of the
Pyrococcus group are anaerobic. It is possible that distinct
disulfide-enriched subgroups have adopted disulfide-
enriched cytosols for different reasons: one for redox control,
and the other for thermostability. It should also be noted that
preference for redox regulation by disulfides over free thiols
may be driven by the presence or identity of other redox
homeostasis systems. Among prokaryotes, the well-studied
glutathione system of eukaryotic redox regulation operates
only in purple bacteria and cyanobacteria (62, 172). A redox
homeostasis system based on coenzyme A may be utilized in
disulfide-enriched archaea (112).
Finally, it is also interesting to note that two of three
internal cellular structures thought to have been acquired
by symbiosis: plastids and mitochondria, have important
redox functions. This suggests acquisition of redox control by
the Last Universal Common Ancestor was a major determi-
nant of success of living organisms in evolution of life on
earth.
C. Redox-regulation of cysteine-based enzymes
Hartley originally classified proteases into four classes
based on their ability to be inhibited by specific classes of
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inhibitors. These four classes are cysteinyl proteases, serine
proteases, aspartic proteases, and metalloenzymes.
Interestingly, the catalytic apparatus of cysteinyl and serine
proteases is astonishingly similar. Cys and Ser, which act as
the nucleophile in reactions in these proteases, are isosteres;
and two other common members of the catalytic triad, His
and Asp, are identical and similarly arranged in three-
dimensional space in both classes of proteases. Furthermore,
Brenner noticed that Ser is specified by two types of codons
which differ by more than one base in multiple groups of
homologous serine proteases of different folds (26). For ex-
ample, inmost trypsin-like serine proteases the catalytic Ser in
encoded by AGN, where N is any of the four bases. However,
in blood trypsin-like serine proteases such as the clotting
factors, Ser is encoded by TCY, where Y is a pyrimidine. In
order for this differential codon usage to have arisen, these
enzymes must have transited through an evolutionary step
that involved Cys or Thr to remain viable proteases. Indeed,
there have since been many cysteinyl proteinases found with
identical folds to serine proteases.
It seems likely this evolutionary step has not occurred
multiple times by coincidence, but is instead a result of se-
lection. Cys may be chosen over Ser in these enzymes when
it is advantageous for the enzyme to be under redox control.
Thus, differential codon usage may have arisen by transit
through such a Cys evolutionary step. Redox control of Cys-
based enzymes by modification of the reactive Cys has been
demonstrated for several examples. One example is the
previously described regulation of activity of the protein
tyrosine phosphatase (PTP) family (Section VI-A) which
encompasses 100 members in humans alone (263). The
mechanism of inhibition of PTP family members suggests a
general mechanism of redox-based inhibition of Cys-based
enzymes. Another example of redox regulation of Cys-based
proteases in Arabidopsis thaliana has recently been demon-
strated. PDI5 is expressed in endothelial cells about to un-
dergo programmed cell death in developing seeds. Three
different Cys proteases interacting with PDI5 have been
identified in yeast two-hybrid screens. PDI5 regulates proper
seed development and the timing of programmed cell death
by chaperoning and inhibiting Cys proteases during their
trafficking to vacuoles (4).
In addition to cysteinyl proteases, Brenner identified mul-
tiple other Cys-based enzymes with differential codon usage.
Many other enzymes have Cys-based reaction mechanisms
including transglutaminases, cathepsins (96, 216), calpain
(85), and caspases (89). These enzymes are also likely to be
under redox control.
IX. Conclusions
Categorizing disulfide switches allows us to recognize
them in novel contexts and should eventually enable their
recognition in protein sequences as well as structures.
Understanding the physicochemical basis of redox-active di-
sulfide switches should enable extrapolation of their behav-
iors from well-characterized examples to novel types. More
work needs to be done to map particular motifs to specific
functions. The association of two forbidden disulfide motifs,
the JSD and the aBDDh, with reversible Zn2þ binding is a step
in this direction. Insight into the molecular mechanisms in-
volved in the etiology of known redox-related diseases such
as Alzheimer’s disease, diabetes, and cancer will undoubtedly
lead to prevention and cures.
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Abbreviations Used
aBDD¼ antiparallel b-Diagonal Disulfide
aBDDh¼ antiparallel b-Diagonal Disulfide
in the hydrogen-bonded site
aCSD¼ antiparallel Cross-Strand Disulfide
ASD¼Along-Strand Disulfide
BCP¼ bacterial comigratory protein
BDD¼ b-Diagonal Disulfide
BHMT¼ betaine-homocysteine
S-methyltransferase
BSD¼Between-Strand Disulfide
CSD¼Cross-Strand Disulfide
Cys¼ cysteine
DSOR¼disulfide oxidoreductase
ER¼ endoplasmic reticulum
FALs¼ familial lateral sclerosis
FTR¼ ferrodoxin-thioredoxin reductase
GABA¼ gamma-aminobutyric acid
Grx¼ glutaredoxin
GSH¼ glutathione
HA¼hemagglutinin
HPLC¼high performance liquid
chromatography
Ig¼ immunglobulin
IHD¼ Inter-Helical Disulfide
IP3¼ inositol triphosphate
IP3R¼ IP3 receptor
JSD¼ Jump-Strand Disulfide
NAPRTase¼nicotinate phosphoribosyltransferase
pBDD¼parallel b-Diagonal Disulfide
pCSD¼parallel Cross-Strand Disulfide
PDB¼protein data bank
PDI¼protein disulfide isomerase
PrP¼prion protein
Prx¼peroxiredoxin
PTP¼protein tyrosine phosphatase
RNS¼ reactive nitrogen species
ROS¼ reactive oxygen species
RT rule¼Richardson–Thornton rule
Sec¼ selenocysteine
SERCA¼ sarco=endoplasmic reticulum
Ca2þ-ATPase
SOD1¼ superoxide dismutase
Trx¼ thioredoxin
TrxR¼ thioredoxin reductase
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